1 | S 90049 | - | - | - | - | [1] 6 6 |
2 | S 90049 - F36 | - | - | - | - | [1] 6 6 |
3 | S 90049 - F38 | - | - | - | - | [1] 6 6 |
4 | S(-)-3-[3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl]-N,4-dimethylbenzamide | - | - | - | - | [1] 46 46 |
5 | S-1226 | - | - | - | - | [1] 299 299 |
6 | S-adenosyl-L-methionine | [1] Methionine Methionine | [2] D00019
D00019
,
D04983
| - | - | [1] 93 93 |
7 | S-adenosyl-methionine (SAMe) capsules | [2] Ademetionine Ademetionine, Methionine | [3] D00019
D00019
,
D04983
,
D07128
| - | - | [1] 93 93 |
8 | S-Ketamin | - | - | - | - | [1] 298 298 |
9 | S-ketamine | [2] Esketamine Esketamine, Ketamine | [3] D00711
D00711
,
D07283
,
D08098
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 70 70 |
10 | S-ketamine & midazolam | [3] Esketamine Esketamine, Ketamine, Midazolam | [6] D00550
D00550
,
D00696
,
D00711
,
D05028
,
D07283
,
D08098
| [21] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [25] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | [1] 70 70 |
11 | S-Warfarin | [2] (S)-Warfarin (S)-Warfarin, Warfarin | [3] D00564
D00564
,
D01280
,
D08682
| [2] NQO1 NQO1, VKORC1 💬 | [7] Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | [1] 13 13 |
12 | S.c. apomorphine | [1] Apomorphine Apomorphine | [2] D02004
D02004
,
D07460
| [2] DRD1 DRD1, DRD2 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
13 | S.c. injections of bovine intestinal Alkaline Phosphatase | [1] Alkaline Phosphatase Alkaline Phosphatase | - | - | - | [1] 46 46 |
14 | S1 | - | - | - | - | [1] 46 46 |
15 | S38 | - | - | - | - | [1] 96 96 |
16 | S78989 | - | - | - | - | [3] 41 41, 50, 56 |
17 | S90049 | - | - | - | - | [1] 6 6 |
18 | S95011 | - | - | - | - | [1] 53 53 |
19 | S95011 concentrate for solution for infusion | - | - | - | - | [1] 53 53 |
20 | SA | - | - | - | - | [5] 6 6, 30, 60, 118, 298 |
21 | SA-001 | - | - | - | - | [1] 298 298 |
22 | SA001 High dose | - | - | - | - | [1] 53 53 |
23 | SA001 Low dose | - | - | - | - | [1] 53 53 |
24 | SA001 Mid dose | - | - | - | - | [1] 53 53 |
25 | SA237 | - | - | - | - | [1] 13 13 |
26 | SABRIL | [1] Vigabatrin Vigabatrin | [1] D00535
D00535
| [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [2] 145 145, 158 |
27 | SABRIL 500 mg, granules for oral solution | [1] Vigabatrin Vigabatrin | [1] D00535
D00535
| [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 158 158 |
28 | Sabril granules for oral use | [1] Vigabatrin Vigabatrin | [1] D00535
D00535
| [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 145 145 |
29 | SABRIL SACHETS | [1] Vigabatrin Vigabatrin | [1] D00535
D00535
| [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 145 145 |
30 | Sabrilex | - | - | - | - | [1] 145 145 |
31 | Sabril® | [1] Vigabatrin Vigabatrin | [1] D00535
D00535
| [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 145 145 |
32 | Saccharomyces | [1] Saccharomyces cerevisiae Saccharomyces cerevisiae | - | - | - | [1] 51 51 |
33 | Saccharomyces Boulardii Oral Tablet | [1] Saccharomyces cerevisiae Saccharomyces cerevisiae | - | - | - | [1] 51 51 |
34 | Sacubitril | [1] Sacubitril Sacubitril | [1] D10225
D10225
| [1] MME MME 💬 | [4] Alzheimer disease Alzheimer disease, Hematopoietic cell lineage, Protein digestion and absorption, Renin-angiotensin system 💬 | [1] 58 58 |
35 | SACUBITRIL VALSARTAN | [2] Sacubitril Sacubitril, Valsartan | [2] D00400
D00400
,
D10225
| [2] AGTR1 AGTR1, MME 💬 | [19] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hematopoietic cell lineage, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Protein digestion and absorption, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 58 58 |
36 | Sacubitril/Valsartan | [2] Sacubitril Sacubitril, Valsartan | [2] D00400
D00400
,
D10225
| [2] AGTR1 AGTR1, MME 💬 | [19] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hematopoietic cell lineage, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Protein digestion and absorption, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 58 58 |
37 | SAF-301 | - | - | - | - | [1] 19 19 |
38 | Safety observation | - | - | - | - | [1] 6 6 |
39 | Saffron 100 | - | - | - | - | [1] 97 97 |
40 | Saffron 50 | - | - | - | - | [1] 97 97 |
41 | Saffron supplement for IBD | - | - | - | - | [1] 97 97 |
42 | Saffron supplementation | - | - | - | - | [1] 301 301 |
43 | Safinamida | [1] Safinamide Safinamide | [1] D10158
D10158
| [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
44 | SAFINAMIDE | [1] Safinamide Safinamide | [1] D10158
D10158
| [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [2] 6 6, 17 |
45 | Safinamide (as add-on therapy) | [1] Safinamide Safinamide | [1] D10158
D10158
| [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
46 | Safinamide + Levodopa | [2] Levodopa Levodopa, Safinamide | [2] D00059
D00059
,
D10158
| [6] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5, MAOB 💬 | [20] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
47 | SAFINAMIDE METANSOLFONATO | [1] Safinamide Safinamide | [1] D10158
D10158
| [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [2] 6 6, 17 |
48 | Safinamide metansolfonato (12 weeks) | [1] Safinamide Safinamide | [1] D10158
D10158
| [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
49 | SAFINAMIDE METHANESULFONATE | [1] Safinamide Safinamide | [1] D10158
D10158
| [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [2] 6 6, 17 |
50 | Safinamide Methanesulfonate 100mg | [1] Safinamide Safinamide | [1] D10158
D10158
| [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
51 | Safinamide Methanesulfonate 150mg | [1] Safinamide Safinamide | [1] D10158
D10158
| [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
52 | Safinamide methansulfonate | [1] Safinamide Safinamide | [1] D10158
D10158
| [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
53 | Safinamide, MAO-B inhibitor | [1] Safinamide Safinamide | [1] D10158
D10158
| [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
54 | Safinimide 50-100 mg/day | - | - | - | - | [1] 6 6 |
55 | Sage | [1] Sage Sage | - | - | - | [1] 6 6 |
56 | Sage leaf | [1] Sage Sage | - | - | - | [1] 6 6 |
57 | SAGE-217 | - | - | - | - | [1] 6 6 |
58 | SAGE-718 | - | - | - | - | [2] 6 6, 8 |
59 | SAIT101 | - | - | - | - | [1] 46 46 |
60 | SAIT101 (proposed rituximab biosimilar) | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 |
61 | SAIT101 (rituximab biosimilar) | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 46 46 |
62 | SAIZEN | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
63 | Saizen 8mg click.easy powder for solution for injection | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
64 | Saizen 8mg click.easy power for solution for injection | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
65 | Saizen® | - | - | - | - | [1] 78 78 |
66 | Saizen® solution for injection (referred as Saizen®) | - | - | - | - | [1] 78 78 |
67 | Salazopyrin | - | - | - | - | [2] 46 46, 271 |
68 | Salazopyrin EN | - | - | - | - | [2] 46 46, 271 |
69 | Salazopyrin EN 500 mg enterotabletter | - | - | - | - | [1] 46 46 |
70 | Salazopyrin EN-Tabs | - | - | - | - | [2] 46 46, 271 |
71 | Salazopyrine | - | - | - | - | [1] 46 46 |
72 | Salazosulfapyridine | [1] Sulfasalazine Sulfasalazine | [1] D00448
D00448
| - | - | [1] 46 46 |
73 | Salbutamol | [1] Salbutamol Salbutamol | [1] D02147
D02147
| [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [9] 3 3, 11, 49, 85, 86, 111, 228, 256, 299 |
74 | Salbutamol (as Salbutamol Sulfate) 2 Mg Oral Tablet | [2] Salbutamol Salbutamol, Sulfate ion | [1] D02147
D02147
| [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 111 111 |
75 | Salbutamol 4Mg Tablet | [1] Salbutamol Salbutamol | [1] D02147
D02147
| [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 |
76 | Salbutamol Only Product in Oral Dose Form | [1] Salbutamol Salbutamol | [1] D02147
D02147
| [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 111 111 |
77 | SALBUTAMOL SULFATE | [2] Salbutamol Salbutamol, Sulfate ion | [1] D02147
D02147
| [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 111 111 |
78 | SALBUTAMOL SULFATE PH. EUR. | [2] Salbutamol Salbutamol, Sulfate ion | [1] D02147
D02147
| [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 |
79 | Salbutamol WZF 4 mg | [1] Salbutamol Salbutamol | [1] D02147
D02147
| [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 |
80 | Salbutamol-ratiopharm® N metered-dose aerosol inhaler | [1] Salbutamol Salbutamol | [1] D02147
D02147
| [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 299 299 |
81 | Salbutamol-ratiopharm® N metereddose aerosol inhaler | [1] Salbutamol Salbutamol | [1] D02147
D02147
| [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 299 299 |
82 | Salbutamolo | - | - | - | - | [1] 299 299 |
83 | Salicylazosulfapyridine | [1] Sulfasalazine Sulfasalazine | [1] D00448
D00448
| - | - | [1] 271 271 |
84 | Salicylic acid | [1] Salicylic acid Salicylic acid | [1] D00097
D00097
| - | - | [1] 97 97 |
85 | Saline | - | - | - | - | [10] 6 6, 13, 17, 53, 67, 78, 86, 97, 168, 299 |
86 | Saline 0.9% inhalation solution | - | - | - | - | [1] 299 299 |
87 | Saline 0.9% NaCl | - | - | - | - | [1] 235 235 |
88 | Saline injection | - | - | - | - | [1] 113 113 |
89 | Saline Intranasal Delivery | - | - | - | - | [1] 6 6 |
90 | Saline Nasal Mist | - | - | - | - | [1] 127 127 |
91 | Saline solution | - | - | - | - | [4] 2 2, 34, 288, 299 |
92 | Saline Solution for Injection | - | - | - | - | [1] 19 19 |
93 | Salmeterol | [1] Salmeterol Salmeterol | [2] D00687
D00687
,
D05792
| [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 299 299 |
94 | Salmon | [1] Salmon, unspecified Salmon, unspecified | - | - | - | [3] 96 96, 97, 225 |
95 | Salofalk | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [2] 96 96, 97 |
96 | Salofalk 1000mg Granu-Stix | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
97 | Salofalk 1000mg Granu-Stix® | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
98 | Salofalk 3g gastro-resistant prolonged-release granules | [2] Manganese citrate Manganese citrate, Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
99 | Salofalk 4g/60ml Klysma | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
100 | Salofalk 500 mg | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 96 96 |
101 | Salofalk Granu-Stix 500 mg | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
102 | Salofalk® 1000mg Granu-Stix® | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
103 | Salofalk® 500 mg gastro-resistant tablet | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
104 | Salofalk® 500 mg tablets | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
105 | Salofalk® 500mg | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
106 | Salofalk® 500mg Granu-Stix® | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
107 | Salsalate | [1] Salsalate Salsalate | [1] D00428
D00428
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 5 5 |
108 | SAM | - | - | - | - | [1] 6 6 |
109 | SAM-e | [1] Ademetionine Ademetionine | [1] D07128
D07128
| - | - | [1] 6 6 |
110 | SAMe | [1] Ademetionine Ademetionine | [1] D07128
D07128
| - | - | [1] 93 93 |
111 | Samsca | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [2] 67 67, 72 |
112 | Samsca 15 mg tablets | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
113 | Samsca 30 mg tablets | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
114 | SAMSCA 7.5 mg oral tablet | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 67 67 |
115 | SAMSCA*10CPR 15MG | [1] Tolvaptan Tolvaptan | [1] D01213
D01213
| [1] AVPR2 AVPR2 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 72 72 |
116 | SAN-300 0.5 mg/kg QW | - | - | - | - | [1] 46 46 |
117 | SAN-300 1.0 mg/kg QW | - | - | - | - | [1] 46 46 |
118 | SAN-300 2.0 mg/kg QOW | - | - | - | - | [1] 46 46 |
119 | SAN-300 4.0 mg/kg QOW | - | - | - | - | [1] 46 46 |
120 | SAN-300 4.0 mg/kg QW | - | - | - | - | [1] 46 46 |
121 | Sandimmum | - | - | - | - | [1] 97 97 |
122 | Sandimmun | - | - | - | - | [2] 97 97, 226 |
123 | Sandimmun 50 mg/ml, infuusiokonsentraatti | - | - | - | - | [1] 97 97 |
124 | Sandimmun Neoral | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 60 60, 97, 226 |
125 | SANDIMMUN NEORAL - 10 MG CAPSULE MOLLI 50 CAPSULE | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 |
126 | SANDIMMUN NEORAL - 100 MG CAPSULE MOLLI 30 CAPSULE | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 |
127 | SANDIMMUN NEORAL - 25 MG CAPSULE MOLLI 50 CAPSULE | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 |
128 | SANDIMMUN NEORAL - 50 MG CAPSULE MOLLI 50 CAPSULE | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 |
129 | SANDIMMUN NEORAL*30CPS 100MG | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 46 46 |
130 | SANDIMMUN NEORAL*50CPS 25MG | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 46 46 |
131 | Sandimmun Optoral | - | - | - | - | [2] 53 53, 113 |
132 | SANDINUM | - | - | - | - | [1] 97 97 |
133 | Sandostatin LAR | [1] Octreotide Octreotide | [2] D00442
D00442
,
D06495
| [1] SSTR2 SSTR2 💬 | [4] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [4] 67 67, 84, 193, 227 |
134 | Sandostatin LAR 20 mg | [1] Octreotide Octreotide | [2] D00442
D00442
,
D06495
| [1] SSTR2 SSTR2 💬 | [4] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 227 227 |
135 | Sandostatina | - | - | - | - | [1] 67 67 |
136 | SANDOSTATINA - LAR 20 MG/2.5 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE FLACONE POLVERE + SIRINGA PRERIEMPITA 2.5 ML + 2 AGHI | - | - | - | - | [1] 67 67 |
137 | SANDOSTATINA LAR | - | - | - | - | [1] 67 67 |
138 | Sandostatina Lar IM Fl 20mg +2F | - | - | - | - | [1] 67 67 |
139 | Sandostatine | - | - | - | - | [1] 96 96 |
140 | Sapropterin | [1] Sapropterin Sapropterin | [1] D08505
D08505
| - | - | [3] 86 86, 124, 240 |
141 | Sapropterin (Kuvan) | [1] Sapropterin Sapropterin | [1] D08505
D08505
| - | - | [1] 240 240 |
142 | SAPROPTERIN DIHYDROCHLORIDE | [1] Sapropterin Sapropterin | [1] D08505
D08505
| - | - | [1] 240 240 |
143 | Sapropterin dihydrochloride (6R-BH4) | [1] Sapropterin Sapropterin | [1] D08505
D08505
| - | - | [1] 86 86 |
144 | Sapropterin dihydrochloride, 6R-BH4, tetrahydrobiopterin | [1] Sapropterin Sapropterin | [1] D08505
D08505
| - | - | [1] 240 240 |
145 | Sapropterin Dihydrocholoride | [1] Sapropterin Sapropterin | [1] D08505
D08505
| - | - | [1] 240 240 |
146 | SAPROPTERIN HYDROCHLORIDE | [1] Sapropterin Sapropterin | [1] D08505
D08505
| - | - | [1] 240 240 |
147 | Sapropterin, sapropterin dihydrochloride | [1] Sapropterin Sapropterin | [1] D08505
D08505
| - | - | [1] 240 240 |
148 | Sapropterin, sapropterin hydrochloride | [1] Sapropterin Sapropterin | [1] D08505
D08505
| - | - | [1] 240 240 |
149 | Sapropterindihydrochloride | - | - | - | - | [1] 240 240 |
150 | Saproterin dihydrochloride | - | - | - | - | [1] 240 240 |
151 | Saquinavir | [1] Saquinavir Saquinavir | [2] D00429
D00429
,
D01160
| - | - | [2] 86 86, 265 |
152 | Saquinavir and ritonavir | [2] Ritonavir Ritonavir, Saquinavir | [3] D00427
D00427
,
D00429
,
D01160
| - | - | [1] 86 86 |
153 | Sar | - | - | - | - | [1] 46 46 |
154 | SAR100842 | - | - | - | - | [2] 51 51, 85 |
155 | SAR113244 | - | - | - | - | [1] 49 49 |
156 | SAR153191 | [1] Sarilumab Sarilumab | [1] D10161
D10161
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [4] 41 41, 46, 107, 271 |
157 | SAR153191 (REGN88) | [1] Sarilumab Sarilumab | [1] D10161
D10161
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 46 46, 107 |
158 | SAR156597 | - | - | - | - | [2] 51 51, 85 |
159 | SAR231893 | - | - | - | - | [2] 51 51, 160 |
160 | SAR236553 | - | - | - | - | [1] 79 79 |
161 | SAR339375 | - | - | - | - | [1] 218 218 |
162 | SAR339658 | - | - | - | - | [2] 13 13, 97 |
163 | SAR402671, GZ402671 o GZ/SAR402671 | - | - | - | - | [2] 19 19, 67 |
164 | SAR402671, GZ402671 or GZ / SAR402671 | - | - | - | - | [1] 19 19 |
165 | SAR402671, GZ402671 or GZ/SAR402671 | - | - | - | - | [3] 6 6, 19, 67 |
166 | SAR421869 | - | - | - | - | [2] 90 90, 303 |
167 | SAR422459 | - | - | - | - | [1] 301 301 |
168 | SAR439459 | - | - | - | - | [1] 274 274 |
169 | SAR441344 | - | - | - | - | [3] 13 13, 49, 53 |
170 | SAR441344 IV | - | - | - | - | [2] 13 13, 49 |
171 | SAR441344 SC | - | - | - | - | [2] 13 13, 49 |
172 | SAR442168 | - | - | - | - | [2] 11 11, 13 |
173 | SAR443820 | - | - | - | - | [1] 2 2 |
174 | SAR444671 | - | - | - | - | [1] 61 61 |
175 | SAR445088 (formerly BIVV020) | - | - | - | - | [1] 14 14 |
176 | SAR650984 | - | - | - | - | [1] 61 61 |
177 | Saracatinab | - | - | - | - | [1] 85 85 |
178 | Saracatinib | [1] Saracatinib Saracatinib | [1] D09664
D09664
| [2] ABL1 ABL1, SRC 💬 | [49] Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | [3] 6 6, 89, 272 |
179 | SARACATINIB DIFUMARATE | [1] Saracatinib Saracatinib | [1] D09664
D09664
| [2] ABL1 ABL1, SRC 💬 | [49] Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | [1] 272 272 |
180 | Sarcosine | [1] Sarcosine Sarcosine | - | - | - | [1] 6 6 |
181 | Sarcosine Capsule | [1] Sarcosine Sarcosine | - | - | - | [1] 6 6 |
182 | Sargramostim | [1] Sargramostim Sargramostim | [1] D05803
D05803
| [1] CSF2RA CSF2RA 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [7] 6 6, 28, 60, 62, 96, 229, 285 |
183 | Sargramostim (Leukine) | [1] Sargramostim Sargramostim | [1] D05803
D05803
| [1] CSF2RA CSF2RA 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 96 96 |
184 | SARILUMAB | [1] Sarilumab Sarilumab | [1] D10161
D10161
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [5] 41 41, 46, 84, 107, 271 |
185 | Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA] | [1] Sarilumab Sarilumab | [1] D10161
D10161
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 |
186 | Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]_#1 | [1] Sarilumab Sarilumab | [1] D10161
D10161
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 84 84 |
187 | Sarilumab SAR153191 | [1] Sarilumab Sarilumab | [1] D10161
D10161
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 41 41 |
188 | Sarilumab SAR153191 (REGN88) | [1] Sarilumab Sarilumab | [1] D10161
D10161
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 46 46, 107 |
189 | SARIZOTAN | [1] Sarizotan Sarizotan | - | - | - | [2] 6 6, 156 |
190 | Sarizotan HC1 | [1] Sarizotan Sarizotan | - | - | - | [1] 6 6 |
191 | Sarizotan HCl | [1] Sarizotan Sarizotan | - | - | - | [1] 6 6 |
192 | Sarizotan Hydrochloride | [1] Sarizotan Sarizotan | - | - | - | [2] 6 6, 156 |
193 | Saroglitazar | [1] Saroglitazar Saroglitazar | - | - | - | [1] 93 93 |
194 | Saroglitazar Magnesium 1 mg | [2] Magnesium Magnesium, Saroglitazar | - | - | - | [1] 93 93 |
195 | Saroglitazar Magnesium 2 mg | [2] Magnesium Magnesium, Saroglitazar | - | - | - | [1] 93 93 |
196 | Saroglitazar magnesium 4 mg | [2] Magnesium Magnesium, Saroglitazar | - | - | - | [1] 93 93 |
197 | SARS-COV-2 mRNA Vaccine | [1] CVnCoV CVnCoV | - | - | - | [1] 13 13 |
198 | SASS | - | - | - | - | [1] 36 36 |
199 | Satavaptan | [1] Satavaptan Satavaptan | - | - | - | [1] 72 72 |
200 | Satavaptan (SR121463) | [1] Satavaptan Satavaptan | - | - | - | [1] 72 72 |
201 | Satavaptan (SR121463B) | [1] Satavaptan Satavaptan | - | - | - | [1] 72 72 |
202 | Sativex | [1] Dronabinol Dronabinol | [1] D00306
D00306
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [2] 2 2, 13 |
203 | Sativex 2,7mg/2,5 mg Solucion para pulverizacion bucal | [1] Dronabinol Dronabinol | [1] D00306
D00306
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 |
204 | Sativex Oromucosal Spray | [1] Dronabinol Dronabinol | [1] D00306
D00306
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 |
205 | Sativex Oromucosal Spray (non-marketed) | [1] Dronabinol Dronabinol | [1] D00306
D00306
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 |
206 | Sativex® | [1] Dronabinol Dronabinol | [1] D00306
D00306
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 13 13 |
207 | SATRALIZUMAB | [1] Satralizumab Satralizumab | [1] D11079
D11079
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 11 11, 13 |
208 | Satralizumab (120 mg/PFS with NSD) | [1] Satralizumab Satralizumab | [1] D11079
D11079
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 |
209 | Satralizumab (120 mg/vial) | [1] Satralizumab Satralizumab | [1] D11079
D11079
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 |
210 | Satralizumab (120mg/vial) | [1] Satralizumab Satralizumab | [1] D11079
D11079
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 |
211 | Satralizumab (r-INN) | [1] Satralizumab Satralizumab | [1] D11079
D11079
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 |
212 | Satralizumab (RO5333787/Enspryng /SA237) | [1] Satralizumab Satralizumab | [1] D11079
D11079
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 |
213 | Satralizumab (RO5333787/Enspryng/SA237) | [1] Satralizumab Satralizumab | [1] D11079
D11079
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 |
214 | Satralizumab (RO5333787/SA237) | [1] Satralizumab Satralizumab | [1] D11079
D11079
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 |
215 | Satrazlizumab (RO5333787/ Enspryng /SA237) | [1] Satralizumab Satralizumab | [1] D11079
D11079
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 13 13 |
216 | Sauerstoff | - | - | - | - | [2] 86 86, 88 |
217 | Saxagliptin | [1] Saxagliptin Saxagliptin | [1] D08996
D08996
| [1] DPP4 DPP4 💬 | [1] Protein digestion and absorption Protein digestion and absorption 💬 | [1] 299 299 |
218 | Saxenda | [1] Liraglutide Liraglutide | [1] D06404
D06404
| [1] GLP1R GLP1R 💬 | [3] Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 193 193 |
219 | SB 681323 | - | - | - | - | [1] 46 46 |
220 | SB-240563 | - | - | - | - | [3] 44 44, 45, 98 |
221 | SB-240563 (mepolizumab) | [1] Mepolizumab Mepolizumab | [1] D04923
D04923
| [1] IL5 IL5 💬 | [13] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | [2] 44 44, 45 |
222 | SB-318 | - | - | - | - | [1] 19 19 |
223 | SB-47171 | - | - | - | - | [1] 19 19 |
224 | SB-47898 | - | - | - | - | [1] 19 19 |
225 | SB-497115 | - | - | - | - | [1] 63 63 |
226 | SB-497115-GR | - | - | - | - | [1] 63 63 |
227 | SB-497115-GR 12.5mg | - | - | - | - | [1] 63 63 |
228 | SB-497115-GR 25mg | - | - | - | - | [1] 63 63 |
229 | SB-497115-GR 50 mg | - | - | - | - | [1] 63 63 |
230 | SB-509 | - | - | - | - | [1] 2 2 |
231 | SB-656933 | - | - | - | - | [1] 97 97 |
232 | SB-656933 Tablets | - | - | - | - | [2] 97 97, 299 |
233 | SB-656933-AAA | - | - | - | - | [1] 299 299 |
234 | SB-681323 | - | - | - | - | [1] 46 46 |
235 | SB-681323 oral tablets | - | - | - | - | [1] 46 46 |
236 | SB-681323 Tablets | - | - | - | - | [1] 46 46 |
237 | SB-683699 | - | - | - | - | [1] 13 13 |
238 | SB-913 | - | - | - | - | [1] 19 19 |
239 | SB-A6P-HRL Donor Vector | - | - | - | - | [1] 19 19 |
240 | SB-FIX | - | - | - | - | [1] 19 19 |
241 | SB-IDUA | - | - | - | - | [1] 19 19 |
242 | SB012 | - | - | - | - | [1] 97 97 |
243 | SB12 (proposed eculizumab biosimilar) | [1] Eculizumab Eculizumab | [1] D03940
D03940
| [1] C5 C5 💬 | [10] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 |
244 | SB2 | - | - | - | - | [1] 46 46 |
245 | SB2 (infliximab biosimilar) | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
246 | SB2 (proposed biosimilar to infliximab) | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
247 | SB4 | - | - | - | - | [3] 46 46, 107, 271 |
248 | SB4 (etanercept biosimilar) | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 107, 271 |
249 | SB4 (proposed biosimilar to etanercept) | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
250 | SB497115 | - | - | - | - | [2] 60 60, 63 |
251 | SB5 | - | - | - | - | [5] 46 46, 96, 97, 107, 271 |
252 | SB5 (proposed biosimilar to adalimumab) | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
253 | SB656933 | - | - | - | - | [1] 299 299 |
254 | SB683699 | - | - | - | - | [1] 13 13 |
255 | SBC-102 | [1] Sebelipase alfa Sebelipase alfa | [1] D10377
D10377
| [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 |
256 | SBC-102, recombinant human lysosomal acid lipase | [1] Sebelipase alfa Sebelipase alfa | [1] D10377
D10377
| [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 |
257 | SBC-103 | - | - | - | - | [1] 19 19 |
258 | SBI-087 | - | - | - | - | [2] 46 46, 49 |
259 | SBT-020 | - | - | - | - | [1] 8 8 |
260 | SC belimumab 200 mg | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [1] 49 49 |
261 | SC golimumab | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
262 | SC interferon beta-1a | [2] Human interferon beta Human interferon beta, Interferon beta-1a | [1] D04554
D04554
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 |
263 | SC interferon beta-1b | [2] Human interferon beta Human interferon beta, Interferon beta-1b | [1] D00746
D00746
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 |
264 | SC Peginterferon beta-1a | [1] Peginterferon beta-1a Peginterferon beta-1a | [1] D10483
D10483
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 |
265 | Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group) | [4] Amitriptyline Amitriptyline, Fluoxetine, Somatotropin, Tramadol | [7] D00326
D00326
,
D00809
,
D00823
,
D01355
,
D02691
,
D07448
,
D08623
| [4] GHR GHR, OPRM1, SLC6A2, SLC6A4 💬 | [9] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Estrogen signaling pathway, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 78 78 |
266 | SC treatment with IGSC, 10% with rHuPH20 followed by IV/IGSC, 10% only (safety) | - | - | - | - | [1] 65 65 |
267 | SC treatment with IGSC, 10% with rHuPH20 followed by SC/IGSC, 10% only (safety) | - | - | - | - | [1] 65 65 |
268 | SC12267 | [1] SC12267 SC12267 | - | - | - | [3] 46 46, 96, 97 |
269 | SC12267 (4SC-101) | [1] SC12267 SC12267 | - | - | - | [3] 46 46, 96, 97 |
270 | ScAAV9.CB.CLN6 | - | - | - | - | [1] 19 19 |
271 | ScAAV9.U1A.hSGSH | - | - | - | - | [1] 19 19 |
272 | ScAAV9.U1A.SGSH | - | - | - | - | [1] 19 19 |
273 | ScAAV9.U7.ACCA | - | - | - | - | [1] 113 113 |
274 | ScAAVrh74.tMCK.hSGCA | - | - | - | - | [1] 113 113 |
275 | SCENESSE | [1] Afamelanotide Afamelanotide | [1] D10511
D10511
| [1] MC1R MC1R 💬 | [2] Melanogenesis Melanogenesis, Neuroactive ligand-receptor interaction 💬 | [3] 159 159, 161, 254 |
276 | SCH 420814 | - | - | - | - | [1] 6 6 |
277 | SCH 420814 10 mg | - | - | - | - | [1] 6 6 |
278 | SCH 420814 100 mg | - | - | - | - | [1] 6 6 |
279 | SCH 900050 | - | - | - | - | [1] 97 97 |
280 | SCH 900259 | - | - | - | - | [1] 46 46 |
281 | SCH 900800 | - | - | - | - | [1] 6 6 |
282 | SCH-58235 | - | - | - | - | [1] 260 260 |
283 | SCH420814 | - | - | - | - | [1] 6 6 |
284 | SCH55700 | - | - | - | - | [1] 98 98 |
285 | SCH900259 | - | - | - | - | [1] 46 46 |
286 | Schisandra chinensis extract | - | - | - | - | [1] 84 84 |
287 | SCID screening | - | - | - | - | [1] 65 65 |
288 | SCIO-469 | - | - | - | - | [1] 46 46 |
289 | SCLEROLYM | - | - | - | - | [1] 13 13 |
290 | Sclerotherapy | - | - | - | - | [1] 227 227 |
291 | SCM | - | - | - | - | [1] 13 13 |
292 | SCM-010 | - | - | - | - | [1] 13 13 |
293 | Scopolamine | [1] Scopolamine Scopolamine | [1] D00138
D00138
| [5] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | [13] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 2 2 |
294 | Scopolamine, atropine, edaravone and dexmedetomidine | [4] Atropine Atropine, Dexmedetomidine, Edaravone, Scopolamine | [9] D00113
D00113
,
D00138
,
D00514
,
D01077
,
D01205
,
D01552
,
D02069
,
D03011
,
D03814
| [8] ADRA2A ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | [14] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 2 2 |
295 | Scorpio NRG posterior stabilized (PS) | - | - | - | - | [1] 46 46 |
296 | SCP | - | - | - | - | [1] 6 6 |
297 | SCRM001_TEVG | - | - | - | - | [1] 210 210 |
298 | SCYX-7158 | [1] SCYX-7158 SCYX-7158 | - | - | - | [1] 65 65 |
299 | SD-101 | - | - | - | - | [1] 36 36 |
300 | SD-101 dermal cream (3%) | - | - | - | - | [1] 36 36 |
301 | SD-101 Dermal Cream (6%) | - | - | - | - | [1] 36 36 |
302 | SD-101-6.0 cream | - | - | - | - | [1] 36 36 |
303 | SD-809 | - | - | - | - | [1] 8 8 |
304 | SD-QIV | - | - | - | - | [1] 46 46 |
305 | SE10599 | - | - | - | - | [1] 299 299 |
306 | Seal oil | - | - | - | - | [1] 46 46 |
307 | Search for exocrine pancreatic insufficiency at week 0 and 12 | - | - | - | - | [1] 96 96 |
308 | Seasonal influenza vaccine | - | - | - | - | [2] 13 13, 46 |
309 | Seasonal influenza vaccine available for the 2012-2013 vaccine campaign | - | - | - | - | [1] 84 84 |
310 | Seasonal Quadrivalent influenza vaccine | - | - | - | - | [1] 13 13 |
311 | Sebelipasa Alfa | [1] Sebelipase alfa Sebelipase alfa | [1] D10377
D10377
| [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 |
312 | Sebelipase Alfa | [1] Sebelipase alfa Sebelipase alfa | [1] D10377
D10377
| [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 |
313 | Sebelipase alfa (SBC-102) | [1] Sebelipase alfa Sebelipase alfa | [1] D10377
D10377
| [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 |
314 | Sebelipase alfa 0.35 mg/kg | [1] Sebelipase alfa Sebelipase alfa | [1] D10377
D10377
| [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 |
315 | Sebelipase alfa 1 mg/kg | [1] Sebelipase alfa Sebelipase alfa | [1] D10377
D10377
| [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 |
316 | Sebelipase alfa 3 mg/kg | [1] Sebelipase alfa Sebelipase alfa | [1] D10377
D10377
| [1] LIPA LIPA 💬 | [3] Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | [1] 19 19 |
317 | Second-generation fumaric acid | [1] Fumaric acid Fumaric acid | [1] D02308
D02308
| - | - | [1] 13 13 |
318 | Secretin | [1] Secretin human Secretin human | - | - | - | [1] 298 298 |
319 | Secukinmab | - | - | - | - | [1] 46 46 |
320 | SECUKINUMAB | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [8] 13 13, 37, 41, 46, 107, 160, 269, 271 |
321 | Secukinumab (150 mg) | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 |
322 | Secukinumab (75 mg) | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 |
323 | Secukinumab (AIN457) | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 46 46 |
324 | Secukinumab (AIN457) 150 mg s.c. | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 |
325 | Secukinumab 150 mg (2 injections per dose | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 269 269 |
326 | Secukinumab 150 mg provided in 1.0 mL pre-filled syringes (PFSs) for sc injection. | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 |
327 | Secukinumab 150 mg/1 mL Solution for injection | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [2] 37 37, 271 |
328 | Secukinumab 150 milligram [Cosentyx] | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 |
329 | Secukinumab 150mg | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 37 37 |
330 | Secukinumab 300 mg | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 41 41 |
331 | Secukinumab 300 mg, s.c. | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 41 41 |
332 | Secukinumab 300mg | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 37 37 |
333 | Secukinumab 75 mg/0.5 ml Solution for injection | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 |
334 | Secukinumab Injection | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 160 160 |
335 | Sedation with IV propofol | [1] Propofol Propofol | [1] D00549
D00549
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 6 6 |
336 | Sedatives/Hypnotics,Other | - | - | - | - | [1] 107 107 |
337 | See below for FCX-007 description) | - | - | - | - | [1] 36 36 |
338 | See D.3.9.3 'Other descriptive name' below | - | - | - | - | [1] 46 46 |
339 | See Intervention Description) | - | - | - | - | [1] 13 13 |
340 | SELADELPAR | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [2] 93 93, 94 |
341 | Seladelpar 10 mg | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
342 | Seladelpar 10 mg Capsule | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
343 | Seladelpar 10 mg or less | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
344 | Seladelpar 5 mg | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
345 | Seladelpar 5 mg Capsule | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
346 | Seladelpar 5-10 mg | [1] Seladelpar Seladelpar | [1] D11256
D11256
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 |
347 | Selective Immunosuppressive agents | - | - | - | - | [1] 96 96 |
348 | Selective Nerve Root Block | - | - | - | - | [1] 70 70 |
349 | Selective Serotonin Uptake Inhibitors (SSRI) | [1] Serotonin Serotonin | - | - | - | [1] 2 2 |
350 | SELEGILINE | [1] Selegiline Selegiline | [2] D00785
D00785
,
D03731
| [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
351 | Selegiline HCl 5 PCH | [1] Selegiline Selegiline | [2] D00785
D00785
,
D03731
| [1] MAOB MAOB 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
352 | Selenium | [1] Selenium Selenium | - | - | - | [4] 13 13, 96, 278, 298 |
353 | Selexipag | [1] Selexipag Selexipag | [1] D09994
D09994
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [6] 47 47, 51, 70, 84, 86, 88 |
354 | Selexipag (Uptravi) | [1] Selexipag Selexipag | [1] D09994
D09994
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
355 | Selexipag, ACT-293987 (NS-304) | [1] Selexipag Selexipag | [1] D09994
D09994
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
356 | Self bone marrow transplant | - | - | - | - | [1] 51 51 |
357 | Seliciclib | [1] Seliciclib Seliciclib | - | - | - | [2] 75 75, 299 |
358 | Selinexor | [1] Selinexor Selinexor | [1] D11222
D11222
| [1] XPO1 XPO1 💬 | [4] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Nucleocytoplasmic transport, Ribosome biogenesis in eukaryotes 💬 | [1] 28 28 |
359 | Selisistat | [1] Selisistat Selisistat | - | - | - | [1] 8 8 |
360 | Selonsertib | [1] Selonsertib Selonsertib | [1] D10988
D10988
| [1] MAP3K5 MAP3K5 💬 | [20] Alcoholic liver disease Alcoholic liver disease, Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Huntington disease, Lipid and atherosclerosis, MAPK signaling pathway, Neurotrophin signaling pathway, Non-alcoholic fatty liver disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Protein processing in endoplasmic reticulum, Sphingolipid signaling pathway, Spinocerebellar ataxia, TNF signaling pathway, Thermogenesis, Tight junction 💬 | [1] 86 86 |
361 | Selumetinib | [1] Selumetinib Selumetinib | [1] D09666
D09666
| [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 |
362 | Selumetinib (AZD6244 hyd sulfate) 25mg/m2 | [2] Selumetinib Selumetinib, Sulfate ion | [1] D09666
D09666
| [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 |
363 | Selumetinib (AZD6244 hyd sulfate) 50mg/dose | [2] Selumetinib Selumetinib, Sulfate ion | [1] D09666
D09666
| [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 |
364 | Selumetinib 10mg capsule | [1] Selumetinib Selumetinib | [1] D09666
D09666
| [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 |
365 | Selumetinib 25mg capsule | [1] Selumetinib Selumetinib | [1] D09666
D09666
| [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 |
366 | Selumetinib capsules 10mg | [1] Selumetinib Selumetinib | [1] D09666
D09666
| [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 |
367 | Selumetinib capsules 25mg | [1] Selumetinib Selumetinib | [1] D09666
D09666
| [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 |
368 | Selumetinib granules in sprinkle capsules for opening 5 mg | [1] Selumetinib Selumetinib | [1] D09666
D09666
| [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 |
369 | Selumetinib granules in sprinkle capsules for opening 7.5 mg | [1] Selumetinib Selumetinib | [1] D09666
D09666
| [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 |
370 | Selumetinib hyd-sulfate | [2] Selumetinib Selumetinib, Sulfate ion | [1] D09666
D09666
| [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 |
371 | Selumetinib Hyd-sulphate | [1] Selumetinib Selumetinib | [1] D09666
D09666
| [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 |
372 | Selumetinib Sulfate | [2] Selumetinib Selumetinib, Sulfate ion | [1] D09666
D09666
| [2] MAP2K1 MAP2K1, MAP2K2 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 |
373 | Semaglutide | [1] Semaglutide Semaglutide | [1] D10025
D10025
| [1] GLP1R GLP1R 💬 | [3] Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 6 6 |
374 | Semapimod | [1] Semapimod Semapimod | - | - | - | [1] 96 96 |
375 | Semi continuous intra-oral administration of LD/CD | - | - | - | - | [1] 6 6 |
376 | Semi-vegetarian diet | - | - | - | - | [1] 97 97 |
377 | SEN0014196 | - | - | - | - | [1] 8 8 |
378 | SEN0014196 (High Dose) | - | - | - | - | [1] 8 8 |
379 | SEN0014196 (Low Dose) | - | - | - | - | [1] 8 8 |
380 | Sendoxan | - | - | - | - | [2] 13 13, 43 |
381 | Sendoxane | - | - | - | - | [1] 13 13 |
382 | Senfrol monotherapy | - | - | - | - | [1] 6 6 |
383 | Senna | [1] Senna leaf Senna leaf | [1] D06751
D06751
| - | - | [1] 291 291 |
384 | SEP-363856 | [1] SEP-363856 SEP-363856 | - | - | - | [1] 6 6 |
385 | SEPTRIN | - | - | - | - | [1] 85 85 |
386 | SER-214 | - | - | - | - | [1] 6 6 |
387 | SER-287 | - | - | - | - | [1] 97 97 |
388 | Seralutinib | - | - | - | - | [1] 86 86 |
389 | Seretide | - | - | - | - | [1] 228 228 |
390 | Serial night time position splint | - | - | - | - | [1] 51 51 |
391 | Sericare | - | - | - | - | [1] 36 36 |
392 | Sericare® | - | - | - | - | [1] 36 36 |
393 | Serine | [1] Serine Serine | [1] D00016
D00016
| - | - | [4] 2 2, 6, 86, 96 |
394 | Serlopitant | [1] Serlopitant Serlopitant | [1] D09378
D09378
| [1] TACR1 TACR1 💬 | [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 36 36 |
395 | Serlopitant Tablet | [1] Serlopitant Serlopitant | [1] D09378
D09378
| [1] TACR1 TACR1 💬 | [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 36 36 |
396 | Seroquel | - | - | - | - | [1] 6 6 |
397 | Serostim®[somatropin (rDNA origin) for injection] | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 265 265 |
398 | Serotonin | [1] Serotonin Serotonin | - | - | - | [1] 2 2 |
399 | Sertraline | [1] Sertraline Sertraline | [2] D00825
D00825
,
D02360
| [1] SLC6A4 SLC6A4 💬 | [2] Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | [2] 6 6, 206 |
400 | Serum albumin | [1] Albumin human Albumin human | [2] D02792
D02792
,
D05424
| - | - | [1] 78 78 |
401 | SERUM ALBUMINE 5% | - | - | - | - | [1] 96 96 |
402 | Serum bovine immunoglobulin | - | - | - | - | [2] 96 96, 97 |
403 | Serum containing Avonex | [1] Interferon beta-1a Interferon beta-1a | [1] D04554
D04554
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 |
404 | Serum Free Avonex | [1] Interferon beta-1a Interferon beta-1a | [1] D04554
D04554
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 |
405 | Serum physiologique 0.9 % | - | - | - | - | [1] 96 96 |
406 | Serum Zn | - | - | - | - | [1] 299 299 |
407 | Sesame oil | [1] Sesame oil Sesame oil | [1] D03314
D03314
| - | - | [1] 3 3 |
408 | SESAME OIL, REFINED | [1] Sesame oil Sesame oil | [1] D03314
D03314
| - | - | [1] 3 3 |
409 | SETANAXIB | - | - | - | - | [1] 93 93 |
410 | Setmelanotide | [1] Setmelanotide Setmelanotide | [1] D11927
D11927
| [1] MC4R MC4R 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 202 202, 265 |
411 | Seton Placement | - | - | - | - | [1] 96 96 |
412 | Setrusumab | [1] Setrusumab Setrusumab | - | - | - | [1] 274 274 |
413 | Sevelamer | [1] Sevelamer Sevelamer | [3] D01983
D01983
,
D06642
,
D08512
| - | - | [2] 235 235, 238 |
414 | Sevoflurane | [1] Sevoflurane Sevoflurane | [1] D00547
D00547
| - | - | [7] 6 6, 21, 22, 34, 98, 225, 296 |
415 | Sevoflurane anesthetics | [1] Sevoflurane Sevoflurane | [1] D00547
D00547
| - | - | [1] 296 296 |
416 | Sezione * D.3.6.2.1 - valore: 400mg alla settimana 0, in seguito 200mg ogni due settimane | - | - | - | - | [1] 96 96 |
417 | SF257 C59 | - | - | - | - | [1] 97 97 |
418 | SF6 | - | - | - | - | [1] 299 299 |
419 | Sfingomielina | - | - | - | - | [1] 79 79 |
420 | SGT-001 | - | - | - | - | [1] 113 113 |
421 | SH U 555 C | - | - | - | - | [1] 13 13 |
422 | Sham | - | - | - | - | [3] 90 90, 211, 303 |
423 | Sham binder | - | - | - | - | [1] 17 17 |
424 | Sham Comparator | - | - | - | - | [1] 141 141 |
425 | Sham compression | - | - | - | - | [2] 6 6, 17 |
426 | Sham Cystoscopy Procedure | - | - | - | - | [1] 226 226 |
427 | Sham Hyperbaric Air | - | - | - | - | [1] 97 97 |
428 | Sham Injection | - | - | - | - | [1] 90 90 |
429 | Sham O2 (medical air) | [2] Medical air Medical air, Oxygen | [1] D00003
D00003
| - | - | [1] 86 86 |
430 | Sham PADN | - | - | - | - | [1] 86 86 |
431 | Sham Procedure | - | - | - | - | [1] 3 3 |
432 | Sham Stimulation | - | - | - | - | [1] 46 46 |
433 | Sham Surgery | - | - | - | - | [1] 6 6 |
434 | Sham tDCS | - | - | - | - | [1] 6 6 |
435 | Sham tPCS | - | - | - | - | [1] 6 6 |
436 | Sham Transcranial Direct Current Stimulation (tDCS) | - | - | - | - | [1] 13 13 |
437 | Sham vagus nerve stimulation | - | - | - | - | [1] 46 46 |
438 | Shingrix | [1] Varicella zoster vaccine (recombinant) Varicella zoster vaccine (recombinant) | - | - | - | [3] 46 46, 96, 97 |
439 | Short Chain Fatty Acids (SCFA) Dietary Supplement | - | - | - | - | [1] 46 46 |
440 | Short-acting Insulin (Actrapid) | - | - | - | - | [1] 299 299 |
441 | Short-course Ocrelizumab | [1] Ocrelizumab Ocrelizumab | [1] D05218
D05218
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
442 | SHP 655 (BAX 930) | - | - | - | - | [1] 64 64 |
443 | SHP611 | - | - | - | - | [1] 19 19 |
444 | SHP647 | - | - | - | - | [2] 96 96, 97 |
445 | SHP655 | - | - | - | - | [1] 64 64 |
446 | SHP675 | - | - | - | - | [1] 19 19 |
447 | SHR-1209 | - | - | - | - | [1] 79 79 |
448 | SHR-1314 | - | - | - | - | [1] 271 271 |
449 | SHR-1906 | - | - | - | - | [1] 85 85 |
450 | SHR0302 | - | - | - | - | [4] 46 46, 96, 97, 271 |
451 | SHR0302 tablets | - | - | - | - | [1] 97 97 |
452 | SHR0302?[14C]SHR0302 | - | - | - | - | [1] 46 46 |
453 | SHR1459 High Dose | - | - | - | - | [1] 222 222 |
454 | SHR1459 Low Dose | - | - | - | - | [1] 222 222 |
455 | SI-722 | - | - | - | - | [1] 226 226 |
456 | Sialic acid | - | - | - | - | [1] 30 30 |
457 | Sialic acid (INN: aceneuramic acid) | [1] Aceneuramic acid Aceneuramic acid | [1] D11016
D11016
| - | - | [1] 30 30 |
458 | Sialic acid, N-acetylneuraminic acid | - | - | - | - | [1] 30 30 |
459 | Sialoendoscopy | - | - | - | - | [1] 53 53 |
460 | Sibofimloc | [1] Sibofimloc Sibofimloc | [1] D11825
D11825
| - | - | [1] 96 96 |
461 | Sifalimumab | [1] Sifalimumab Sifalimumab | [1] D09668
D09668
| [13] IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 | [25] Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 49 49 |
462 | Sifalimumab 1,200 mg | [1] Sifalimumab Sifalimumab | [1] D09668
D09668
| [13] IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 | [25] Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 49 49 |
463 | Sifalimumab 200 mg | [1] Sifalimumab Sifalimumab | [1] D09668
D09668
| [13] IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 | [25] Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 49 49 |
464 | Sifalimumab 600 mg | [1] Sifalimumab Sifalimumab | [1] D09668
D09668
| [13] IFNA1 IFNA1, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA2, IFNA21, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8 💬 | [25] Alcoholic liver disease Alcoholic liver disease, Autoimmune thyroid disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, PI3K-Akt signaling pathway, Pathways in cancer, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway, Tuberculosis 💬 | [1] 49 49 |
465 | Sifol | - | - | - | - | [1] 6 6 |
466 | SIFROL | [1] Pramipexole Pramipexole | [2] D00559
D00559
,
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
467 | Sifrol 0,088 | [1] Pramipexole Pramipexole | [2] D00559
D00559
,
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
468 | Sifrol 0,18 | [1] Pramipexole Pramipexole | [2] D00559
D00559
,
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
469 | Sifrol 0,35 | [1] Pramipexole Pramipexole | [2] D00559
D00559
,
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
470 | Sifrol 0,7 | [1] Pramipexole Pramipexole | [2] D00559
D00559
,
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
471 | Sifrol, 0,35 mg Tablette | [1] Pramipexole Pramipexole | [2] D00559
D00559
,
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
472 | Sifrol, 0,70 mg Tablette | [1] Pramipexole Pramipexole | [2] D00559
D00559
,
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
473 | Sifrol, Mirapexin | [1] Pramipexole Pramipexole | [2] D00559
D00559
,
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
474 | Sifrol® | - | - | - | - | [1] 6 6 |
475 | Sigmoidoscopy | - | - | - | - | [1] 97 97 |
476 | SIGNIFOR | [1] Pasireotide Pasireotide | [1] D10147
D10147
| [4] SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | [4] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 75 75 |
477 | SILDENAF | - | - | - | - | [1] 86 86 |
478 | Sildenafil | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [17] 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 |
479 | Sildenafil (50 mg) | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 85 85 |
480 | Sildenafil (Acute-1 hour) | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 299 299 |
481 | Sildenafil (as citrate) | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
482 | Sildenafil (REVATIO) | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
483 | Sildenafil (Revatio) 20 mg TID | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
484 | Sildenafil (Subchronic-4 weeks) | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 299 299 |
485 | Sildenafil 20 mg tablets | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 278 278 |
486 | Sildenafil 20mg | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 |
487 | Sildenafil 20mg and Bosentan 62.5mg | [2] Bosentan Bosentan, Sildenafil | [4] D01227
D01227
,
D02229
,
D07538
,
D08514
| [3] EDNRA EDNRA, EDNRB, PDE5A 💬 | [11] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 |
488 | Sildenafil 40mg oral capsule | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 299 299 |
489 | Sildenafil and Losartan | [2] Losartan Losartan, Sildenafil | [4] D00357
D00357
,
D02229
,
D08146
,
D08514
| [2] AGTR1 AGTR1, PDE5A 💬 | [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 85 85 |
490 | Sildenafil by injection | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 210 210 |
491 | Sildenafil citrate | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [4] 51 51, 85, 86, 225 |
492 | Sildenafil citrate (UK-92,480) | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
493 | Sildenafil Filmtabletten | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
494 | Sildenafil singly or in association with Bosentan | [2] Bosentan Bosentan, Sildenafil | [4] D01227
D01227
,
D02229
,
D07538
,
D08514
| [3] EDNRA EDNRA, EDNRB, PDE5A 💬 | [11] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
495 | Sildenafil therapy | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
496 | Sildenafil25 mg | - | - | - | - | [1] 17 17 |
497 | SILDENAFILO | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
498 | Silicon | [1] Silicon Silicon | - | - | - | [1] 6 6 |
499 | Silikis 3µg/g Salbe | - | - | - | - | [1] 37 37 |
500 | Silodosin | [1] Silodosin Silodosin | [1] D01965
D01965
| [1] ADRA1A ADRA1A 💬 | [7] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 6 6 |
501 | Silodyx | [1] Silodosin Silodosin | [1] D01965
D01965
| [1] ADRA1A ADRA1A 💬 | [7] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 13 13 |
502 | Siltuximab | [1] Siltuximab Siltuximab | [1] D09669
D09669
| [1] IL6 IL6 💬 | [51] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [2] 28 28, 331 |
503 | Silver | [1] Silver Silver | - | - | - | [2] 35 35, 162 |
504 | Silycus | - | - | - | - | [1] 75 75 |
505 | Simethicone | [1] Simethicone Simethicone | [1] D05841
D05841
| - | - | [2] 13 13, 96 |
506 | SimpleCare | - | - | - | - | [1] 36 36 |
507 | SimpleJectTM | - | - | - | - | [1] 46 46 |
508 | Simplex® Bone Cement | - | - | - | - | [1] 46 46 |
509 | SIMPONI | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 97, 271 |
510 | Simponi (Golimumab) | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 |
511 | SIMPONI - 50 MG-SOLUZIONE PER INIEZIONE IN PENNA PRERIEMPITA-USO SOTTOCUTANEO-PENNA PRERIEMPITA(VETRO) -0.5 ML 3 (3X1) PENNE PRERIEMPITE | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
512 | Simponi 50 mg injeksjonsvæske, oppløsning i ferdigfylt sprøyte. | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
513 | SIMPONI 50 mg solución inyectable en pluma precargada | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
514 | Simponi® | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [3] 46 46, 97, 271 |
515 | Simponi® (Golimumab) | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 |
516 | Simtuzimab | - | - | - | - | [1] 94 94 |
517 | Simtuzumab | [1] Simtuzumab Simtuzumab | - | - | - | [2] 85 85, 94 |
518 | Simulect | [1] Basiliximab Basiliximab | [1] D03058
D03058
| [1] IL2RA IL2RA 💬 | [11] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 66 66, 97 |
519 | SimvaHEXAL® 40 mg Filmtabletten | - | - | - | - | [1] 13 13 |
520 | Simvastatin | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [21] 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 |
521 | Simvastatin 20 mg | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 46 46 |
522 | Simvastatin 20mg/5ml Oral Suspension | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 34 34 |
523 | Simvastatin 40 mg | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 86 86 |
524 | Simvastatin 40 mg film-coated tablets | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 13 13 |
525 | Simvastatin 40 mg tablets | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 86 86 |
526 | Simvastatin 40mg | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 94 94 |
527 | Simvastatin Alternova | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 13 13 |
528 | Simvastatin in relapsing remitting multiple sclerosis | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 13 13 |
529 | Simvastatin Susp. | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 310 310 |
530 | Simvastatin treatment for 28 days | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 299 299 |
531 | Simvastatin-ratiopharm | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 162 162 |
532 | Simvastatin-ratiopharm® | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 162 162 |
533 | Simvastatina | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 13 13 |
534 | Simvastatina Sandoz 40 mg comprimidos recubiertos con película EFG | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 13 13 |
535 | Simvastatine | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [3] 6 6, 13, 288 |
536 | Simvastatine Sandoz 40 mg filmomhulde tabletten | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 13 13 |
537 | Simvastatine Sandoz 40mg deelbare filmomhulde tabletten | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 13 13 |
538 | SIN ASIGNAR | - | - | - | - | [1] 299 299 |
539 | SIN LV Mediated ex vivo transduced autologous fibroblasts expressing codon-optimised COL7A1 | - | - | - | - | [1] 36 36 |
540 | SIN RV-mediated COL7A1 corrected autologous skin equivalent | - | - | - | - | [1] 36 36 |
541 | SINEMET | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
542 | Sinemet (carbidopa/levodopa) | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
543 | Sinemet (comparator) | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
544 | Sinemet (levodopa/carbidopa) | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
545 | SINEMET - 100 MG + 25 MG COMPRESSE 50 COMPRESSE DIVISIBILI | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
546 | SINEMET 10-100 | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
547 | SINEMET 100 mg + 25 mg compresse | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
548 | SINEMET 100 mg + 25 mg tablets | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
549 | SINEMET 125 | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
550 | Sinemet 125 mg | - | - | - | - | [1] 6 6 |
551 | Sinemet 200mg/50mg | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
552 | SINEMET 25-100 | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
553 | Sinemet 25-100 Oral Tablet | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
554 | SINEMET 25/100 | - | - | - | - | [1] 6 6 |
555 | SINEMET CR | - | - | - | - | [1] 6 6 |
556 | Sinemet CR 25Mg-100Mg Extended-Release Tablet | [2] Carbidopa Carbidopa, Manganese citrate | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
557 | Sinemet IR | - | - | - | - | [1] 6 6 |
558 | SINEMET Plus | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
559 | Sinemet plus (levodopa/carbidopa) | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
560 | SINEMET*50CPR 100MG+25MG | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
561 | Sinemet-Plus Tablets | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
562 | Sinemet® | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
563 | Sinemet® 100/25 | - | - | - | - | [1] 6 6 |
564 | Sinemet® 100/25 mg | - | - | - | - | [1] 6 6 |
565 | Sinemet® controlled release (Carbidopa/levodopa) | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
566 | Sinemet® CR | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
567 | Sinemet® CR 100/25 | - | - | - | - | [1] 6 6 |
568 | SINEMET® Plus 25 mg/100 mg Tablets | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
569 | SINEMET®-Plus Tablets | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
570 | Sinemet®25-100 | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
571 | Single dose C2N-8E12 | - | - | - | - | [1] 5 5 |
572 | Single dose reduced | - | - | - | - | [1] 2 2 |
573 | Single dose standard | - | - | - | - | [1] 2 2 |
574 | Single dose-group A | - | - | - | - | [1] 97 97 |
575 | Single infusion of 124I-labeled anti-amyloid mAb 11-1F4: 2 mCi (1 mg) | - | - | - | - | [1] 28 28 |
576 | Single intravenous (IV) dose of human Low Density Lipoprotein Receptor (LDLR) Gene Therapy | - | - | - | - | [1] 79 79 |
577 | Single Photon Emission Computed Tomography | - | - | - | - | [1] 34 34 |
578 | Single-point cane (SPC) | - | - | - | - | [1] 13 13 |
579 | Single-pulse transcranial magnetic stimulation (spTMS) | - | - | - | - | [1] 13 13 |
580 | Single-use autoinjector | - | - | - | - | [1] 13 13 |
581 | Single-use autoinjector with a prefilled liquid Avonex syringe | [1] Interferon beta-1a Interferon beta-1a | [1] D04554
D04554
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 |
582 | Singulair | [1] Montelukast Montelukast | [2] D00529
D00529
,
D08229
| [1] CYSLTR1 CYSLTR1 💬 | [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 228 228 |
583 | Singulair (Montelukast Sodium) | [1] Montelukast Montelukast | [2] D00529
D00529
,
D08229
| [1] CYSLTR1 CYSLTR1 💬 | [2] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 228 228 |
584 | Sinvacor | - | - | - | - | [1] 51 51 |
585 | SINVACOR*28CPR RIV 20MG | - | - | - | - | [1] 51 51 |
586 | Sinvastatina Sandoz 40 mg comprimidos revestidos por película | - | - | - | - | [1] 13 13 |
587 | Siponimid | - | - | - | - | [1] 50 50 |
588 | Siponimob | - | - | - | - | [1] 13 13 |
589 | SIPONIMOD | [1] Siponimod Siponimod | [1] D11460
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 50 |
590 | Siponimod 0,25 mg | [1] Siponimod Siponimod | [1] D11460
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
591 | Siponimod 0.25 mg tablet | [1] Siponimod Siponimod | [1] D11460
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 50 |
592 | Siponimod 0.5 mg tablet | [1] Siponimod Siponimod | [1] D11460
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 50 |
593 | Siponimod 1 mg | [1] Siponimod Siponimod | [1] D11460
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
594 | Siponimod 1 mg tablet | [1] Siponimod Siponimod | [1] D11460
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 50 |
595 | Siponimod 2 mg | [1] Siponimod Siponimod | [1] D11460
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
596 | Siponimod 2 mg tablet | [1] Siponimod Siponimod | [1] D11460
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [2] 13 13, 50 |
597 | SIPONIMOD FUMARIC ACID | [2] Fumaric acid Fumaric acid, Siponimod | [2] D02308
D02308
,
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
598 | SIRIO*30CPR EFF 25MG+100MG | - | - | - | - | [1] 6 6 |
599 | Sirolimus | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [36] 6 6, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 |
600 | Sirolimus (formerly known as Rapamycin) | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 35 35 |
601 | Sirolimus (study drug)+ACE inhibitor + statin | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 66 66 |
602 | Sirolimus 0,1% crème | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 278 278, 280 |
603 | Sirolimus 0.2% | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 158 158 |
604 | Sirolimus 0.4% | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 158 158 |
605 | Sirolimus 1mg/mL | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 278 278, 280 |
606 | Sirolimus 2 MG | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 17 17 |
607 | Sirolimus 2% | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 36 36, 192 |
608 | Sirolimus and Hydroxychloroquine 200 mg | [2] Hydroxychloroquine Hydroxychloroquine, Sirolimus | [2] D00753
D00753
,
D08050
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 89 89 |
609 | Sirolimus and Hydroxychloroquine 400 mg | [2] Hydroxychloroquine Hydroxychloroquine, Sirolimus | [2] D00753
D00753
,
D08050
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 89 89 |
610 | Sirolimus Ointment | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 84 84 |
611 | Sirolimus Oral Liquid Product 1mg/mL | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [1] 278 278 |
612 | Sirolimus Oral Product | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 89 89, 158 |
613 | Sirolimus, 2% | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 36 36, 192 |
614 | Sirukuma | - | - | - | - | [1] 46 46 |
615 | Sirukumab | [1] Sirukumab Sirukumab | [1] D10080
D10080
| [1] IL6 IL6 💬 | [51] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [2] 41 41, 46 |
616 | Sirukumab 100 mg | [1] Sirukumab Sirukumab | [1] D10080
D10080
| [1] IL6 IL6 💬 | [51] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [1] 46 46 |
617 | Sirukumab 50 mg | [1] Sirukumab Sirukumab | [1] D10080
D10080
| [1] IL6 IL6 💬 | [51] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | [1] 46 46 |
618 | Sitagliptin | [1] Sitagliptin Sitagliptin | [1] D08516
D08516
| [1] DPP4 DPP4 💬 | [1] Protein digestion and absorption Protein digestion and absorption 💬 | [4] 6 6, 75, 233, 299 |
619 | Sitagliptin and Metformin | [2] Metformin Metformin, Sitagliptin | [3] D00944
D00944
,
D04966
,
D08516
| [3] DPP4 DPP4, PRKAA1, PRKAA2 💬 | [21] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Protein digestion and absorption, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 233 233 |
620 | Sitaxentan | [1] Sitaxentan Sitaxentan | [1] D07171
D07171
| [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
621 | Sitaxentan sodium | [1] Sitaxentan Sitaxentan | [1] D07171
D07171
| [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
622 | Sitaxsentan | [1] Sitaxentan Sitaxentan | [1] D07171
D07171
| [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
623 | Sitaxsentan alone | [1] Sitaxentan Sitaxentan | [1] D07171
D07171
| [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
624 | Sitaxsentan and Sildenafil | [2] Sildenafil Sildenafil, Sitaxentan | [3] D02229
D02229
,
D07171
,
D08514
| [2] EDNRA EDNRA, PDE5A 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
625 | SITAXSENTAN SODIUM | [1] Sitaxentan Sitaxentan | [1] D07171
D07171
| [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
626 | Site specific standard of care comparison | - | - | - | - | [2] 38 38, 39 |
627 | Sitosterol | [1] beta-Sitosterol beta-Sitosterol | [1] D08518
D08518
| - | - | [1] 260 260 |
628 | SIVASTIN | - | - | - | - | [1] 15 15 |
629 | Sivatin | - | - | - | - | [1] 13 13 |
630 | Sivatin 40 mg film-coated tablets | - | - | - | - | [1] 13 13 |
631 | Sivelestat | [1] Sivelestat Sivelestat | [1] D03788
D03788
| [1] ELANE ELANE 💬 | [3] Neutrophil extracellular trap formation Neutrophil extracellular trap formation, Systemic lupus erythematosus, Transcriptional misregulation in cancer 💬 | [3] 13 13, 85, 96 |
632 | SK&F101468 | - | - | - | - | [1] 6 6 |
633 | Skeletal survey | - | - | - | - | [1] 19 19 |
634 | SKF-101468A | - | - | - | - | [1] 6 6 |
635 | SKI-606 | - | - | - | - | [1] 67 67 |
636 | SKI-O-703 | - | - | - | - | [1] 46 46 |
637 | SKI-O-703 capsule | - | - | - | - | [1] 46 46 |
638 | Skin biopsy | - | - | - | - | [2] 19 19, 84 |
639 | Skin biopsy for the primary fibroblast culture and a 15 ml blood sample (3 unnamed samples of 5ml) in each of the 4 SRT patients included. | - | - | - | - | [1] 102 102 |
640 | Skincerity | - | - | - | - | [2] 34 34, 158 |
641 | Skincerity plus sirolimus/rapamycin | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 34 34, 158 |
642 | Skinercity plus sirolimus/rapamycin | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [2] 34 34, 158 |
643 | Sleep assessment | - | - | - | - | [1] 13 13 |
644 | Sleep parameters | - | - | - | - | [1] 113 113 |
645 | SLIT Amikacin | [1] Amikacin Amikacin | [2] D00865
D00865
,
D02543
| - | - | [1] 299 299 |
646 | Slit Lamp assessment and intra-ocular pressure measurement | - | - | - | - | [1] 19 19 |
647 | SLIT(TM) Amikacin | [1] Amikacin Amikacin | [2] D00865
D00865
,
D02543
| - | - | [1] 299 299 |
648 | Slow Dose Titration Group of Subcutaneous Treprostinil | [1] Treprostinil Treprostinil | [1] D06213
D06213
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
649 | SLS | - | - | - | - | [1] 2 2 |
650 | SLS-005 | - | - | - | - | [1] 2 2 |
651 | SLS-005 Trehalose | [1] Trehalose Trehalose | - | - | - | [1] 2 2 |
652 | SLV308 | - | - | - | - | [1] 6 6 |
653 | SLV308 (mono) hydro | - | - | - | - | [1] 6 6 |
654 | SLV308 (mono) hydrochlo | - | - | - | - | [1] 6 6 |
655 | SLV308 (mono) hydrochlori | - | - | - | - | [1] 6 6 |
656 | SLV308 (mono) hydrochloride | - | - | - | - | [1] 6 6 |
657 | SLV308 (mono)hydrochloride | - | - | - | - | [1] 6 6 |
658 | SLV308 hydrochloride | - | - | - | - | [1] 6 6 |
659 | SLV308(mono)hydrochloride | - | - | - | - | [1] 6 6 |
660 | SLV339 | - | - | - | - | [1] 298 298 |
661 | SM03 | - | - | - | - | [1] 46 46 |
662 | SM04646 | - | - | - | - | [1] 85 85 |
663 | SM101 | - | - | - | - | [3] 49 49, 63, 66 |
664 | SM101 20mg/mL | - | - | - | - | [1] 63 63 |
665 | SM101 5mg/mL | - | - | - | - | [1] 63 63 |
666 | SM934 | - | - | - | - | [1] 49 49 |
667 | Small bowel follow trough | - | - | - | - | [1] 96 96 |
668 | SMART | - | - | - | - | [1] 3 3 |
669 | Smartject Device delivery of Golimumab | [1] Golimumab Golimumab | [1] D04358
D04358
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 97 97 |
670 | SmartPill Motility System & PillCam Patency Capsule | - | - | - | - | [1] 299 299 |
671 | SMderpept | - | - | - | - | [1] 13 13 |
672 | SMILAGENIN | [1] Smilagenin Smilagenin | - | - | - | [1] 6 6 |
673 | Smofkabiven | [1] Sodium glycerophosphate Sodium glycerophosphate | [1] D10489
D10489
| - | - | [1] 66 66 |
674 | SMOFKABIVEN - EMULSIONE PER INFUSIONE SENZA ELETTROLITI 1 SACCA BIOFINE MULTICOMPARTIMENTATE DA 493 ML | [1] Sodium glycerophosphate Sodium glycerophosphate | [1] D10489
D10489
| - | - | [1] 66 66 |
675 | SMOFLipid | [1] Medium-chain triglycerides Medium-chain triglycerides | - | - | - | [1] 96 96 |
676 | Smoked Cannabis | [1] Medical Cannabis Medical Cannabis | - | - | - | [1] 13 13 |
677 | Smoking cigarettes | - | - | - | - | [2] 96 96, 97 |
678 | Smoking of cannabis | [1] Medical Cannabis Medical Cannabis | - | - | - | [2] 96 96, 97 |
679 | SMP-114 | - | - | - | - | [1] 46 46 |
680 | SMT C1100 | - | - | - | - | [1] 113 113 |
681 | SMT C1100 (F5 | - | - | - | - | [1] 113 113 |
682 | SMT C1100 (F5) | - | - | - | - | [1] 113 113 |
683 | SMT C1100 (F6 | - | - | - | - | [1] 113 113 |
684 | SMT C1100 (F6) | - | - | - | - | [1] 113 113 |
685 | SMX | - | - | - | - | [1] 299 299 |
686 | Snack beverage | - | - | - | - | [1] 299 299 |
687 | SND 919 CL2 Y | - | - | - | - | [1] 6 6 |
688 | SND 919 CL2Y | - | - | - | - | [1] 6 6 |
689 | SNN0029 | - | - | - | - | [1] 2 2 |
690 | SNN0029 infusion solution | - | - | - | - | [1] 2 2 |
691 | SNN0031 | - | - | - | - | [1] 6 6 |
692 | SNSP113 | - | - | - | - | [1] 299 299 |
693 | SNT-MC17 | - | - | - | - | [1] 113 113 |
694 | Sobetirome | [1] Sobetirome Sobetirome | [1] D09381
D09381
| [1] THRB THRB 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | [1] 20 20 |
695 | Sobetirome (NV1205) | [1] Sobetirome Sobetirome | [1] D09381
D09381
| [1] THRB THRB 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | [1] 20 20 |
696 | SOBI003 | - | - | - | - | [1] 19 19 |
697 | SOC | - | - | - | - | [2] 47 47, 158 |
698 | SoC Therapy | - | - | - | - | [1] 171 171 |
699 | SODIO ASCORBATO DC.IT | - | - | - | - | [1] 10 10 |
700 | Sodio phenylbutyrate | [1] Phenylbutyric acid Phenylbutyric acid | - | - | - | [1] 2 2 |
701 | Sodio valproato | - | - | - | - | [1] 144 144 |
702 | Sodium (R)-8-methyl-2-(3-methylbenzofuran-2-yl)-5-(1-(tetrahydro-2H-pyran-4-yl)ethoxy)quinoline-4-ca | - | - | - | - | [1] 299 299 |
703 | Sodium (S)-3-(4-hydroxyphenyl)-2-(2-((S)-1-((S)-1-palmitoylpyrrolidine-2-carbonyl)pyrrolidine-2-carboxamido)acetamido)propanoate | - | - | - | - | [1] 97 97 |
704 | Sodium 4-Phenylbutyrate | [1] Phenylbutyric acid Phenylbutyric acid | - | - | - | [1] 299 299 |
705 | Sodium 4-Phenylbutyrate (4PBA) | [1] Phenylbutyric acid Phenylbutyric acid | - | - | - | [1] 299 299 |
706 | Sodium acetate | [2] Acetate Acetate, Sodium acetate | [1] D01779
D01779
| - | - | [1] 81 81 |
707 | SODIUM ACID PYROPHOSPHATE | - | - | - | - | [1] 166 166 |
708 | SODIUM ACID PYROPHOSPHATE SAPP ROR 28 FOOD GRADE | - | - | - | - | [1] 166 166 |
709 | SODIUM ALGINATE | [1] Alginic acid Alginic acid | [1] D02324
D02324
| - | - | [1] 299 299 |
710 | Sodium aurothiomalate | [1] Sodium aurothiomalate Sodium aurothiomalate | [1] D00992
D00992
| - | - | [1] 46 46 |
711 | Sodium aurothiomalate (intramuscular gold) | [1] Sodium aurothiomalate Sodium aurothiomalate | [1] D00992
D00992
| - | - | [1] 46 46 |
712 | Sodium Bicarbonate | [1] Sodium bicarbonate Sodium bicarbonate | [1] D01203
D01203
| - | - | [1] 299 299 |
713 | SODIUM BICARBONATE BP | [1] Sodium bicarbonate Sodium bicarbonate | [1] D01203
D01203
| - | - | [1] 299 299 |
714 | Sodium chlorid | - | - | - | - | [1] 13 13 |
715 | Sodium chloride | [2] Chloride ion Chloride ion, Sodium chloride | [1] D02056
D02056
| - | - | [21] 6 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 67, 78, 96, 168, 193, 227, 228, 271, 288, 299 |
716 | Sodium chloride (7%) | [2] Chloride ion Chloride ion, Sodium chloride | [1] D02056
D02056
| - | - | [1] 299 299 |
717 | Sodium chloride 0,9% | [2] Chloride ion Chloride ion, Sodium chloride | [1] D02056
D02056
| - | - | [1] 299 299 |
718 | Sodium Chloride 0.9% | [2] Chloride ion Chloride ion, Sodium chloride | [1] D02056
D02056
| - | - | [2] 14 14, 227 |
719 | Sodium chloride 6% | [2] Chloride ion Chloride ion, Sodium chloride | [1] D02056
D02056
| - | - | [1] 299 299 |
720 | SODIUM CHLORIDE 7% | [2] Chloride ion Chloride ion, Sodium chloride | [1] D02056
D02056
| - | - | [1] 299 299 |
721 | SODIUM CHLORIDE PH. EUR. | [2] Chloride ion Chloride ion, Sodium chloride | [1] D02056
D02056
| - | - | [1] 299 299 |
722 | Sodium Chloride solution | [2] Chloride ion Chloride ion, Sodium chloride | [1] D02056
D02056
| - | - | [3] 11 11, 13, 228 |
723 | SODIUM CHLORIDE SOLUTION 0.9% | [2] Chloride ion Chloride ion, Sodium chloride | [1] D02056
D02056
| - | - | [3] 60 60, 288, 299 |
724 | Sodium Chloride Solvent | [2] Chloride ion Chloride ion, Sodium chloride | [1] D02056
D02056
| - | - | [1] 228 228 |
725 | Sodium citrate | [1] Sodium citrate Sodium citrate | [2] D01781
D01781
,
D05855
| - | - | [4] 67 67, 214, 215, 235 |
726 | SODIUM CROMOGLICATE | [1] Cromoglicic acid Cromoglicic acid | [2] D00526
D00526
,
D07753
| - | - | [1] 85 85 |
727 | Sodium fluoride | [1] Sodium fluoride Sodium fluoride | [1] D00943
D00943
| - | - | [1] 51 51 |
728 | Sodium fluoride 18F | [1] Sodium fluoride Sodium fluoride | [1] D00943
D00943
| - | - | [1] 51 51 |
729 | Sodium hyaluronate | [1] Hyaluronic acid Hyaluronic acid | [1] D08043
D08043
| - | - | [2] 53 53, 97 |
730 | Sodium iodide | [2] Iodide Iodide, Sodium iodide | [3] D04874
D04874
,
D05328
,
D05863
| - | - | [1] 34 34 |
731 | Sodium Nitrate | [2] Nitrate Nitrate, Sodium nitrate | [1] D02313
D02313
| - | - | [2] 58 58, 113 |
732 | Sodium Nitrate - double dose | [2] Nitrate Nitrate, Sodium nitrate | [1] D02313
D02313
| - | - | [1] 113 113 |
733 | SODIUM NITRITE | [1] Nitrite Nitrite | - | - | - | [2] 86 86, 299 |
734 | Sodium Nitrite Inhalation Solution | [1] Nitrite Nitrite | - | - | - | [1] 86 86 |
735 | SODIUM NITROPRUSSIDE | [1] Nitroprusside Nitroprusside | [1] D00614
D00614
| - | - | [1] 51 51 |
736 | Sodium Oxybate | [2] Sodium oxybate Sodium oxybate, gamma-Hydroxybutyric acid | [1] D05866
D05866
| - | - | [2] 6 6, 149 |
737 | Sodium phenylbutyrate | [1] Phenylbutyric acid Phenylbutyric acid | - | - | - | [4] 2 2, 3, 8, 251 |
738 | Sodium phenylbutyrate (NaPB) | [1] Phenylbutyric acid Phenylbutyric acid | - | - | - | [1] 3 3 |
739 | Sodium phosphate enema, oral rifaximin and polyethylene glycol | [3] Phosphate ion Phosphate ion, Polyethylene glycol, Rifaximin | [2] D02554
D02554
,
D03370
| - | - | [1] 6 6 |
740 | Sodium Picosulfate, Magnesium Oxide and Citric Acid | [4] Citric acid Citric acid, Magnesium, Magnesium oxide, Picosulfuric acid | [3] D00037
D00037
,
D01167
,
D01222
| - | - | [1] 291 291 |
741 | Sodium Picosulfate/Magnesium Citrate Laxative | [4] Magnesium Magnesium, Magnesium citrate, Picosulfuric acid, Polyethylene glycol | [2] D03265
D03265
,
D03370
| - | - | [1] 97 97 |
742 | SODIUM PYRUVATE | - | - | - | - | [2] 2 2, 67 |
743 | Sodium Pyruvate in 0.9% Sodium Chloride Solution | [2] Chloride ion Chloride ion, Sodium chloride | [1] D02056
D02056
| - | - | [1] 299 299 |
744 | Sodium sulfate | [2] Sodium sulfate Sodium sulfate, Sulfate ion | [1] D05877
D05877
| - | - | [1] 28 28 |
745 | Sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth | [2] Dextrose, unspecified form Dextrose, unspecified form, Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
746 | Sodium Thiosulfate | - | - | - | - | [2] 50 50, 51 |
747 | Sodium Thiosulfate 10% | - | - | - | - | [2] 50 50, 51 |
748 | SODIUM THIOSULFATE PENTAHYDRATE | - | - | - | - | [2] 50 50, 51 |
749 | Sodium Valproate | [1] Valproic acid Valproic acid | [1] D00399
D00399
| [7] ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | [17] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [4] 2 2, 90, 102, 256 |
750 | Sodium valproate 200 mg gastro-resistant tablets | [1] Valproic acid Valproic acid | [1] D00399
D00399
| [7] ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | [17] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 233 233 |
751 | Sodium Valproate 200Mg E/C Tablet | [1] Valproic acid Valproic acid | [1] D00399
D00399
| [7] ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | [17] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 233 233 |
752 | Sodium Valproate Wockhardt 200mg Gastro-Resistant tablets | [1] Valproic acid Valproic acid | [1] D00399
D00399
| [7] ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | [17] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 233 233 |
753 | Sodium-[o-[(2,6-dichlorophenyl)-amino]- phenyl]-acetate | [1] Acetate Acetate | - | - | - | [1] 46 46 |
754 | Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate | [1] Acetate Acetate | - | - | - | [1] 46 46 |
755 | Sodiumchloride | - | - | - | - | [1] 67 67 |
756 | Sofosbuvir | [1] Sofosbuvir Sofosbuvir | [1] D10366
D10366
| - | - | [1] 19 19 |
757 | Softacort | - | - | - | - | [1] 53 53 |
758 | Sofusa DoseConnect | - | - | - | - | [1] 46 46 |
759 | Solaris | - | - | - | - | [2] 62 62, 109 |
760 | Solid food-based intervention | - | - | - | - | [1] 96 96 |
761 | Solid state catheter | - | - | - | - | [1] 51 51 |
762 | Solifenacin | [1] Solifenacin Solifenacin | [2] D01269
D01269
,
D08522
| [1] CHRM3 CHRM3 💬 | [11] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | [3] 6 6, 13, 53 |
763 | Solifenacin Succinate | [1] Solifenacin Solifenacin | [2] D01269
D01269
,
D08522
| [1] CHRM3 CHRM3 💬 | [11] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | [1] 13 13 |
764 | Solifenacin Succinate (VESIcare) | [1] Solifenacin Solifenacin | [2] D01269
D01269
,
D08522
| [1] CHRM3 CHRM3 💬 | [11] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | [1] 6 6 |
765 | SOLIGEN | - | - | - | - | [1] 6 6 |
766 | SOLIRIS | [1] Eculizumab Eculizumab | [1] D03940
D03940
| [1] C5 C5 💬 | [10] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [7] 11 11, 13, 14, 61, 62, 109, 222 |
767 | Soliris (eculizumab) | [1] Eculizumab Eculizumab | [1] D03940
D03940
| [1] C5 C5 💬 | [10] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 |
768 | Soliris (R) | [1] Eculizumab Eculizumab | [1] D03940
D03940
| [1] C5 C5 💬 | [10] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 61 61 |
769 | SOLIRIS - 300 MG CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO 1 FLACONCINO (VETRO) 30 ML (10 MG/ML) | [1] Eculizumab Eculizumab | [1] D03940
D03940
| [1] C5 C5 💬 | [10] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [3] 13 13, 62, 109 |
770 | Soliris 300 | [1] Eculizumab Eculizumab | [1] D03940
D03940
| [1] C5 C5 💬 | [10] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 |
771 | SOLIRIS 300 mg concentrado para solución para perfusión | [1] Eculizumab Eculizumab | [1] D03940
D03940
| [1] C5 C5 💬 | [10] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 109 109 |
772 | Soliris 300 mg concentrate for solution for infusion | [1] Eculizumab Eculizumab | [1] D03940
D03940
| [1] C5 C5 💬 | [10] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 |
773 | Soliris 300mg/30ml | [1] Eculizumab Eculizumab | [1] D03940
D03940
| [1] C5 C5 💬 | [10] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 |
774 | Soliris® | [1] Eculizumab Eculizumab | [1] D03940
D03940
| [1] C5 C5 💬 | [10] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 |
775 | SOLIRIS® (eculizumab) injection, for intravenous use | [1] Eculizumab Eculizumab | [1] D03940
D03940
| [1] C5 C5 💬 | [10] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 |
776 | Solondo | - | - | - | - | [1] 222 222 |
777 | SOLU MEDROL | - | - | - | - | [1] 56 56 |
778 | SOLU MEDROL - 125 MG/2 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 125 MG/2 ML | - | - | - | - | [3] 13 13, 14, 53 |
779 | SOLU MEDROL - 40 MG/ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 40 MG/ML | - | - | - | - | [1] 56 56 |
780 | SOLU MEDROL - 500 MG/8 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE DI POLVERE DA 500 MG+ FIALA SOLVENTE DA 8 ML | - | - | - | - | [1] 56 56 |
781 | Solu-Cortef | [2] Hydrocortisone cypionate Hydrocortisone cypionate, Hydrocortisone succinate | [2] D00976
D00976
,
D01442
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 6 6, 81, 83 |
782 | Solu-Cortef (hydrocortisone) | [1] Hydrocortisone Hydrocortisone | [1] D00088
D00088
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 83 83 |
783 | Solu-Cortef, powder for solution for injection, 100mg, and 'Act-O-Vial' | [2] Hydrocortisone Hydrocortisone, Hydrocortisone succinate | [2] D00088
D00088
,
D01442
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 6 6 |
784 | Solu-Medrol | [1] Methylprednisolone hemisuccinate Methylprednisolone hemisuccinate | [1] D05000
D05000
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [7] 13 13, 49, 50, 51, 53, 97, 211 |
785 | Solu-medrol inj. PSO LQF 40mg | [1] Methylprednisolone hemisuccinate Methylprednisolone hemisuccinate | [1] D05000
D05000
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 50 50 |
786 | Solu-Medrone | - | - | - | - | [3] 51 51, 83, 162 |
787 | Solu-Medrone 125mg | - | - | - | - | [1] 46 46 |
788 | Solu-Medrone 2 Gram | - | - | - | - | [1] 46 46 |
789 | Solu-Medrone 2mg | - | - | - | - | [1] 46 46 |
790 | SOLU-MODERIN 1 g | - | - | - | - | [1] 13 13 |
791 | Soluble Fc receptor | - | - | - | - | [1] 49 49 |
792 | Soluble Fc-gamma receptor IIb | - | - | - | - | [1] 49 49 |
793 | Soluble fiber supplementation | - | - | - | - | [1] 299 299 |
794 | SOLUBLE PREDNISOLONE TABLETS | [1] Prednisolone Prednisolone | [8] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 145 145 |
795 | Soluble Ve cadherin | - | - | - | - | [1] 51 51 |
796 | Solucion de Cloruro de Sodio | - | - | - | - | [1] 228 228 |
797 | Solucion de cloruro de sodio Sodium Chloride Solution | [2] Chloride ion Chloride ion, Sodium chloride | [1] D02056
D02056
| - | - | [1] 228 228 |
798 | SoluMedrol | - | - | - | - | [1] 13 13 |
799 | Solumedrol IM 125mg/2ml | - | - | - | - | [1] 13 13 |
800 | Solution de chlorhydrate de dopamine anaérobie | [1] Dopamine Dopamine | [2] D00633
D00633
,
D07870
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
801 | Soluzione di levodopa/carbidopa | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
802 | Solvente Cloruro de Sodio Sodium Chloride Solvent | [2] Chloride ion Chloride ion, Sodium chloride | [1] D02056
D02056
| - | - | [1] 228 228 |
803 | Solvente de Cloruro de Sodio | - | - | - | - | [1] 228 228 |
804 | SOM0226 | - | - | - | - | [1] 28 28 |
805 | SOM230 | - | - | - | - | [2] 74 74, 75 |
806 | SOM230 300µg | - | - | - | - | [1] 75 75 |
807 | SOM230 600µg | - | - | - | - | [1] 75 75 |
808 | SOM230 900µg | - | - | - | - | [1] 75 75 |
809 | SOM230 LAR | - | - | - | - | [1] 75 75 |
810 | SOM230 LAR 10 mg | - | - | - | - | [1] 75 75 |
811 | SOM230 LAR 30 mg | - | - | - | - | [1] 75 75 |
812 | SOM230 LAR, 20 mg | - | - | - | - | [1] 75 75 |
813 | SOM230 s.c. | - | - | - | - | [1] 75 75 |
814 | SOM230, 300micrograms | - | - | - | - | [1] 75 75 |
815 | SOM230, 600 micrograms | - | - | - | - | [1] 75 75 |
816 | SOM230, 900 micrograms | - | - | - | - | [1] 75 75 |
817 | SOM230B | - | - | - | - | [1] 75 75 |
818 | SOM3355 100mg BID | - | - | - | - | [1] 8 8 |
819 | SOM3355 200mg BID | - | - | - | - | [1] 8 8 |
820 | Somalgen | - | - | - | - | [1] 299 299 |
821 | SOMAPACITAN | [1] Somapacitan Somapacitan | [1] D11194
D11194
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
822 | Somapacitan 10 mg/1.5ml PDS290 | [1] Somapacitan Somapacitan | [1] D11194
D11194
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
823 | Somapacitan 10 mg/1.5ml PDS290S | [1] Somapacitan Somapacitan | [1] D11194
D11194
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
824 | Somapacitan 15 mg/1.5ml PDS290 | [1] Somapacitan Somapacitan | [1] D11194
D11194
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
825 | Somapacitan 5 mg/1.5ml PDS290 | [1] Somapacitan Somapacitan | [1] D11194
D11194
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
826 | Somatic gene-therapy by X-CGD | - | - | - | - | [1] 65 65 |
827 | SomatoKine/IPLEX | - | - | - | - | [1] 113 113 |
828 | Somatorelin | [1] Somatorelin Somatorelin | [1] D08523
D08523
| [1] GHRHR GHRHR 💬 | [2] Growth hormone synthesis, secretion and action Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬 | [2] 13 13, 78 |
829 | Somatostatin | [1] Somatostatin Somatostatin | [1] D07431
D07431
| [5] SSTR1 SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬 | [4] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 67 67, 78 |
830 | Somatotropin | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [4] 3 3, 65, 78, 236 |
831 | Somatotropine | - | - | - | - | [1] 78 78 |
832 | Somatrogon | [1] Somatrogon Somatrogon | [1] D10990
D10990
| - | - | [1] 78 78 |
833 | Somatrogon (Genetical Recombination) | [1] Somatrogon Somatrogon | [1] D10990
D10990
| - | - | [1] 78 78 |
834 | Somatropin | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [19] 2 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299 |
835 | Somatropin (DNA origin) | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 19 19 |
836 | Somatropin (INN) recombinant DNA orgin, Escherichia coli | [2] Escherichia coli Escherichia coli, Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
837 | Somatropin (rDNA origin) | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
838 | Somatropin (recombinant DNA origin produced in E. coli) | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
839 | SOMATROPIN (recombinant DNA-derived human growth hormone) | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
840 | Somatropin - adult cohort | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 193 193 |
841 | Somatropin - GH naïve pediatric cohort | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 193 193 |
842 | Somatropin - GH treated cohort | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 193 193 |
843 | Somatropin [rDNA origin] for injection | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [2] 46 46, 96 |
844 | Somatropin AQ | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
845 | SOMATROPIN FOR INJECTION | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
846 | Somatropin Injection | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
847 | Somatropin(rhGH) | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 96 96 |
848 | Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate | [5] Arginine Arginine, Clonidine, Estradiol, Estradiol valerate, Somatotropin | [12] D00105
D00105
,
D00281
,
D00604
,
D01413
,
D01617
,
D01953
,
D02691
,
D02982
,
D04061
,
D04063
,
D04064
,
D04065
| [6] ADRA2A ADRA2A, ADRA2B, ADRA2C, ESR1, ESR2, GHR 💬 | [16] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 65 65 |
849 | SOMATROPINA | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
850 | Somatropine | - | - | - | - | [1] 78 78 |
851 | Somatuline | - | - | - | - | [2] 67 67, 298 |
852 | Somatuline Autogel | [1] Lanreotide Lanreotide | - | - | - | [1] 67 67 |
853 | Somatuline Autogel 90 mg | [1] Lanreotide Lanreotide | - | - | - | [1] 298 298 |
854 | Somatuline Autosolution | - | - | - | - | [1] 67 67 |
855 | Somavaratan | [1] Somavaratan Somavaratan | [1] D11193
D11193
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
856 | Somavaratan (VRS-317) | [1] Somavaratan Somavaratan | [1] D11193
D11193
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
857 | Sonic toothbrush | - | - | - | - | [1] 51 51 |
858 | Sonic toothbrush (Philips Sonicare) and water flosser (Philips Sonicare AirFloss) | [1] Water Water | [1] D00001
D00001
| - | - | [1] 51 51 |
859 | Sonlicromanol | [1] Sonlicromanol Sonlicromanol | - | - | - | [1] 21 21 |
860 | SonoVue | [1] Sulfur hexafluoride Sulfur hexafluoride | [1] D05962
D05962
| - | - | [1] 96 96 |
861 | Sorafenib | [1] Sorafenib Sorafenib | [2] D06272
D06272
,
D08524
| [8] BRAF BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [2] 34 34, 86 |
862 | Sorafenib (as tosylate) | [1] Sorafenib Sorafenib | [2] D06272
D06272
,
D08524
| [8] BRAF BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬 | [89] Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | [1] 34 34 |
863 | SORAPRAZAN | - | - | - | - | [1] 301 301 |
864 | Sorbitol | [1] Sorbitol Sorbitol | [1] D00096
D00096
| - | - | [2] 6 6, 10 |
865 | SORBITOLO | - | - | - | - | [1] 10 10 |
866 | Sortis | - | - | - | - | [1] 93 93 |
867 | Sortis 10 mg | - | - | - | - | [1] 93 93 |
868 | SOTATERCEPT | [1] Sotatercept Sotatercept | [1] D09670
D09670
| [1] ACVR2A ACVR2A 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [2] 86 86, 284 |
869 | Sotatercept - 45 mg/vial | [1] Sotatercept Sotatercept | [1] D09670
D09670
| [1] ACVR2A ACVR2A 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [1] 86 86 |
870 | Sotatercept - 60 mg/vial | [1] Sotatercept Sotatercept | [1] D09670
D09670
| [1] ACVR2A ACVR2A 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [1] 86 86 |
871 | Sotatercept with prednisone boost | [2] Prednisone Prednisone, Sotatercept | [2] D00473
D00473
,
D09670
| [2] ACVR2A ACVR2A, NR3C1 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Neuroactive ligand-receptor interaction, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [1] 284 284 |
872 | SOTICLESTAT | - | - | - | - | [2] 140 140, 144 |
873 | Sotrastaurin | [1] Sotrastaurin Sotrastaurin | [1] D09671
D09671
| [4] PRKCD PRKCD, PRKCE, PRKCH, PRKCQ 💬 | [29] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 97 97 |
874 | Sotrastaurin (INN) acetate | [2] Acetate Acetate, Sotrastaurin | [1] D09671
D09671
| [4] PRKCD PRKCD, PRKCE, PRKCH, PRKCQ 💬 | [29] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 97 97 |
875 | Soy bread | - | - | - | - | [1] 298 298 |
876 | Soy protein | - | - | - | - | [2] 6 6, 96 |
877 | Soy protein isolate | - | - | - | - | [1] 227 227 |
878 | Soya Bean oil | [1] Bean Bean | - | - | - | [1] 96 96 |
879 | Soybean | [1] Soybean Soybean | - | - | - | [1] 97 97 |
880 | SOYBEAN PHOSPHATIDYLCHOLINE | [2] Lecithin Lecithin, Soybean | [1] D04682
D04682
| - | - | [1] 97 97 |
881 | SPARC0921 | - | - | - | - | [1] 13 13 |
882 | SPARSENTAN | [1] Sparsentan Sparsentan | [1] D11776
D11776
| [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 66 66, 218, 222 |
883 | Sparsentan compresse | [1] Sparsentan Sparsentan | [1] D11776
D11776
| [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 |
884 | Sparsentan tablets | [1] Sparsentan Sparsentan | [1] D11776
D11776
| [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 |
885 | Sparsentan tablets/ Over-encapsulated Sparsentan tablets | [1] Sparsentan Sparsentan | [1] D11776
D11776
| [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 |
886 | Sparsentan tablets/Over-encapsulated Sparsentan tablets | [1] Sparsentan Sparsentan | [1] D11776
D11776
| [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 |
887 | Sparsentan tablets/over-encapsulated Spasenten tablets | [1] Sparsentan Sparsentan | [1] D11776
D11776
| [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 |
888 | Sparsentan tablets/Overencapsulated Sparsentan tablets | [1] Sparsentan Sparsentan | [1] D11776
D11776
| [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 66 66 |
889 | Sparsentan/Over-encapsulated Sparsentan tablet | [1] Sparsentan Sparsentan | [1] D11776
D11776
| [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 222 222 |
890 | Sparsentan/Over-encapsulated Sparsentan tablets | [1] Sparsentan Sparsentan | [1] D11776
D11776
| [2] AGTR1 AGTR1, EDNRA 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 222 222 |
891 | SPD476 | - | - | - | - | [1] 97 97 |
892 | SPD476 (mesalazine) | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
893 | SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
894 | SPECT | - | - | - | - | [1] 6 6 |
895 | SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM | [1] Ioflupane I-123 Ioflupane I-123 | - | - | - | [1] 2 2 |
896 | SPECT imaging | - | - | - | - | [1] 6 6 |
897 | SPECT Imaging (180 Minutes post-injection) | - | - | - | - | [1] 46 46 |
898 | SPECT Imaging (60 Minutes post-injection) | - | - | - | - | [1] 46 46 |
899 | Speech and modified barium swallow study | [1] Barium Barium | - | - | - | [1] 19 19 |
900 | Speech pathology evaluation | - | - | - | - | [1] 78 78 |
901 | Sperti Del Sol Lamp | - | - | - | - | [1] 299 299 |
902 | Spesolilmab | - | - | - | - | [1] 96 96 |
903 | Spesolimab | [1] Spesolimab Spesolimab | [1] D12066
D12066
| [1] IL1RL2 IL1RL2 💬 | [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [3] 37 37, 96, 97 |
904 | Spesolimab IV infusion | [1] Spesolimab Spesolimab | [1] D12066
D12066
| [1] IL1RL2 IL1RL2 💬 | [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1] 97 97 |
905 | Spesolimab SC solution for injection | [1] Spesolimab Spesolimab | [1] D12066
D12066
| [1] IL1RL2 IL1RL2 💬 | [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1] 97 97 |
906 | SPH3127 | - | - | - | - | [1] 97 97 |
907 | Spheramine (BAY86-5280) | - | - | - | - | [1] 6 6 |
908 | Sphingomyelin | - | - | - | - | [1] 79 79 |
909 | SPI-1005 Ebselen 200mg Capsule x1 | [1] Ebselen Ebselen | - | - | - | [1] 299 299 |
910 | SPI-1005 Ebselen 200mg Capsule x2 | [1] Ebselen Ebselen | - | - | - | [1] 299 299 |
911 | SPI-1005 Ebselen 200mg Capsule x3 | [1] Ebselen Ebselen | - | - | - | [1] 299 299 |
912 | SPIF | - | - | - | - | [1] 95 95 |
913 | Spikevax | [1] Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | [1] D12114
D12114
| - | - | [1] 13 13 |
914 | Spinal anesthesia with tourniquet | - | - | - | - | [1] 46 46 |
915 | Spinal anesthesia without tourniquet | - | - | - | - | [1] 46 46 |
916 | Spinal tap | - | - | - | - | [1] 25 25 |
917 | Spinraza | [1] Nusinersen Nusinersen | [1] D10881
D10881
| [1] SMN2 SMN2 💬 | - | [1] 3 3 |
918 | Spirit1 | - | - | - | - | [1] 2 2 |
919 | Spiriva | [1] Tiotropium Tiotropium | - | - | - | [1] 299 299 |
920 | Spiriva Respimat | [1] Tiotropium Tiotropium | - | - | - | [1] 299 299 |
921 | Spiriva Respimat 2.5 mcg | [1] Tiotropium Tiotropium | - | - | - | [1] 299 299 |
922 | Spiriva Respimat 2.5 microgram | [1] Tiotropium Tiotropium | - | - | - | [1] 299 299 |
923 | Spiriva Respimat 2.5 microgram, solution for inhalation | [1] Tiotropium Tiotropium | - | - | - | [1] 299 299 |
924 | Spirix | - | - | - | - | [1] 225 225 |
925 | Spirometry | - | - | - | - | [1] 299 299 |
926 | Spironolactone | [1] Spironolactone Spironolactone | [1] D00443
D00443
| [1] NR3C2 NR3C2 💬 | [1] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | [7] 58 58, 67, 86, 113, 210, 218, 225 |
927 | Spironolactone (drug) | [1] Spironolactone Spironolactone | [1] D00443
D00443
| [1] NR3C2 NR3C2 💬 | [1] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | [1] 210 210 |
928 | Spironolactone and conivaptan | [2] Conivaptan Conivaptan, Spironolactone | [3] D00443
D00443
,
D01236
,
D07748
| [3] AVPR1A AVPR1A, AVPR2, NR3C2 💬 | [6] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬 | [1] 86 86 |
929 | Spironolactone captopril carvedilol | [3] Captopril Captopril, Carvedilol, Spironolactone | [4] D00251
D00251
,
D00255
,
D00443
,
D03415
| [7] ACE ACE, ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, NR3C2 💬 | [19] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Chemical carcinogenesis - receptor activation, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
930 | Spiropent | - | - | - | - | [2] 6 6, 13 |
931 | Spirulina | [1] Spirulina platensis Spirulina platensis | - | - | - | [1] 299 299 |
932 | Spirulina platensis | [1] Spirulina platensis Spirulina platensis | - | - | - | [1] 299 299 |
933 | SPK-3006 | - | - | - | - | [1] 256 256 |
934 | Spleen sample | - | - | - | - | [1] 61 61 |
935 | SPM 926 | - | - | - | - | [1] 6 6 |
936 | SPM 962 | - | - | - | - | [1] 6 6 |
937 | SPM927 | - | - | - | - | [1] 149 149 |
938 | SPM962 | - | - | - | - | [1] 6 6 |
939 | Sporanox | [1] Itraconazole Itraconazole | [1] D00350
D00350
| - | - | [2] 227 227, 299 |
940 | Sporanox 10 mg/ml Oral Solution | [1] Itraconazole Itraconazole | [1] D00350
D00350
| - | - | [1] 299 299 |
941 | SpotOn balance glasses | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 6 6 |
942 | SPP-004 | - | - | - | - | [1] 21 21 |
943 | SPR001 | - | - | - | - | [1] 81 81 |
944 | SPT3162 | - | - | - | - | [1] 145 145 |
945 | Sputum | - | - | - | - | [1] 299 299 |
946 | Sputum Collection | - | - | - | - | [1] 299 299 |
947 | SPX-101 | - | - | - | - | [1] 299 299 |
948 | SPY imaging | - | - | - | - | [1] 291 291 |
949 | SQ Fludarabine | [1] Fludarabine Fludarabine | [2] D01907
D01907
,
D07966
| [1] RRM1 RRM1 💬 | [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | [1] 49 49 |
950 | SQJZ herbal mixtures | - | - | - | - | [1] 6 6 |
951 | SR-fampridine | [1] Dalfampridine Dalfampridine | [1] D04127
D04127
| [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 |
952 | SR121463B | - | - | - | - | [1] 72 72 |
953 | SR140333B | - | - | - | - | [1] 97 97 |
954 | SR57667B | - | - | - | - | [1] 6 6 |
955 | SRK-015 | - | - | - | - | [1] 3 3 |
956 | Srolimus | - | - | - | - | [1] 89 89 |
957 | SRP-4045 | - | - | - | - | [1] 113 113 |
958 | SRP-4053 | - | - | - | - | [1] 113 113 |
959 | SRP-5051 | - | - | - | - | [1] 113 113 |
960 | SRP-9001 | - | - | - | - | [1] 113 113 |
961 | SRT2104 | - | - | - | - | [1] 97 97 |
962 | SRX246 | - | - | - | - | [1] 8 8 |
963 | SS-1 | - | - | - | - | [1] 53 53 |
964 | SS-20 | - | - | - | - | [1] 8 8 |
965 | Ss-Adrenergic cocktail | - | - | - | - | [1] 299 299 |
966 | Ss-hydroxybuturate esters | - | - | - | - | [1] 256 256 |
967 | Ss-interferon | - | - | - | - | [1] 13 13 |
968 | Ss-mercaptoethylamine Hydrochloride & 2-aminoethanethiol Hydrochloride | [1] Cysteamine Cysteamine | [2] D03634
D03634
,
D03635
| - | - | [1] 19 19 |
969 | SSGJ-613 | - | - | - | - | [1] 107 107 |
970 | SSP-004184 100 mg | - | - | - | - | [1] 284 284 |
971 | SSP-004184 100 mg Capsule | - | - | - | - | [1] 284 284 |
972 | SSP-004184 250 mg | - | - | - | - | [1] 284 284 |
973 | SSP-004184 250 mg Capsule | - | - | - | - | [1] 284 284 |
974 | SSP-004184 375 mg | - | - | - | - | [1] 284 284 |
975 | SSP-004184 375 mg Capsule | - | - | - | - | [1] 284 284 |
976 | SSP-004184 50 mg | - | - | - | - | [1] 284 284 |
977 | SSP-004184 50 mg Capsule | - | - | - | - | [1] 284 284 |
978 | SSP-004184 500 mg | - | - | - | - | [1] 284 284 |
979 | SSP-004184 500 mg Capsule | - | - | - | - | [1] 284 284 |
980 | SSP-004184AQ 100 mg | - | - | - | - | [1] 284 284 |
981 | SSP-004184AQ 100 mg Capsule | - | - | - | - | [1] 284 284 |
982 | SSP-004184AQ 200 mg | - | - | - | - | [1] 284 284 |
983 | SSP-004184AQ 200 mg Capsule | - | - | - | - | [1] 284 284 |
984 | SSP-004184AQ 250 mg | - | - | - | - | [1] 284 284 |
985 | SSP-004184AQ 250 mg Capsule | - | - | - | - | [1] 284 284 |
986 | SSP-004184AQ 375 mg | - | - | - | - | [1] 284 284 |
987 | SSP-004184AQ 375 mg Capsule | - | - | - | - | [1] 284 284 |
988 | SSP-004184AQ 50 mg | - | - | - | - | [1] 284 284 |
989 | SSP-004184AQ 50 mg Capsule | - | - | - | - | [1] 284 284 |
990 | SSR150106 | - | - | - | - | [1] 46 46 |
991 | SSR150106XB | - | - | - | - | [1] 46 46 |
992 | SSZ | - | - | - | - | [1] 271 271 |
993 | ST 261 | - | - | - | - | [1] 97 97 |
994 | ST-0529 | - | - | - | - | [1] 97 97 |
995 | ST-920 | - | - | - | - | [1] 19 19 |
996 | ST10 | - | - | - | - | [1] 96 96 |
997 | ST10-021 | - | - | - | - | [2] 96 96, 97 |
998 | ST200 | - | - | - | - | [1] 265 265 |
999 | ST261 | - | - | - | - | [1] 97 97 |
1000 | STA 5326 mesylate | - | - | - | - | [1] 46 46 |
1001 | STA-5326 | - | - | - | - | [2] 65 65, 96 |
1002 | STA-5326 mesylate | - | - | - | - | [1] 96 96 |
1003 | STA-6838, STA-5326 m, S38 | - | - | - | - | [1] 96 96 |
1004 | Stable isotope infusions | - | - | - | - | [1] 96 96 |
1005 | Stable weekly dose of methotrexate | [1] Methotrexate Methotrexate | [2] D00142
D00142
,
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
1006 | Stage II Surgical repair | - | - | - | - | [1] 211 211 |
1007 | Stalevo | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
1008 | Stalevo (levodopa/ carbidopa/ entacapone) | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] D00059
D00059
,
D00558
,
D00781
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1009 | Stalevo (levodopa/carbidopa/entacapona) | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
1010 | Stalevo (levodopa/carbidopa/entacapone) | [3] Carbidopa Carbidopa, Entacapone, Levodopa | [3] D00059
D00059
,
D00558
,
D00781
| [7] COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [17] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
1011 | Stalevo 100 | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
1012 | Stalevo 100 mg/ 25 mg/ 200 mg Filmtabletten | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
1013 | Stalevo 100 mg/25 mg / 200 mg | - | - | - | - | [1] 6 6 |
1014 | Stalevo 100/25/200 mg | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
1015 | Stalevo 150 | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
1016 | Stalevo 150/37.5/200 mg | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
1017 | STALEVO*100CPR 100/25/200MG | [1] Entacapone Entacapone | [1] D00781
D00781
| [1] COMT COMT 💬 | [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [1] 6 6 |
1018 | STALEVO*100CPR 50/12,5/200MG | [1] Entacapone Entacapone | [1] D00781
D00781
| [1] COMT COMT 💬 | [4] Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | [1] 6 6 |
1019 | Stalevo® | - | - | - | - | [1] 6 6 |
1020 | Standard 2 hours-infusion | - | - | - | - | [2] 96 96, 97 |
1021 | Standard analgesia use [Fentanyl] | [1] Fentanyl Fentanyl | [2] D00320
D00320
,
D01399
| [1] OPRM1 OPRM1 💬 | [3] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | [1] 70 70 |
1022 | Standard analgesia use [Hydromorphone] | [1] Hydromorphone Hydromorphone | [2] D00839
D00839
,
D08047
| [1] OPRM1 OPRM1 💬 | [3] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | [1] 70 70 |
1023 | Standard analgesia use [Oxygen] | [1] Oxygen Oxygen | [1] D00003
D00003
| - | - | [1] 70 70 |
1024 | Standard analgesia use [Volatile Anesthesia] | - | - | - | - | [1] 70 70 |
1025 | Standard Care | - | - | - | - | [2] 81 81, 299 |
1026 | Standard care Hyaluronic acid eye drops | [1] Hyaluronic acid Hyaluronic acid | [1] D08043
D08043
| - | - | [1] 53 53 |
1027 | Standard continuous antiretroviral therapy | - | - | - | - | [1] 265 265 |
1028 | Standard DMARDs (Disease Modifying Anti Rheumatic Drugs) | - | - | - | - | [1] 46 46 |
1029 | Standard dose of HCQ | - | - | - | - | [1] 49 49 |
1030 | Standard dose of rituximab | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 49 49 |
1031 | Standard Dose YPT-01 | - | - | - | - | [1] 299 299 |
1032 | Standard Formula | - | - | - | - | [1] 299 299 |
1033 | Standard formula (Enfamil) | - | - | - | - | [1] 299 299 |
1034 | Standard gadolinium contrast | [1] Gadolinium Gadolinium | - | - | - | [1] 13 13 |
1035 | Standard glucocorticoid therapy | - | - | - | - | [1] 81 81 |
1036 | Standard interval dosing | - | - | - | - | [1] 13 13 |
1037 | Standard LD/CD | - | - | - | - | [1] 6 6 |
1038 | Standard MS DMT | - | - | - | - | [1] 13 13 |
1039 | Standard MS DMTs | - | - | - | - | [1] 13 13 |
1040 | Standard Nutritional Supplement + PERT | - | - | - | - | [1] 299 299 |
1041 | Standard of Care | - | - | - | - | [10] 6 6, 13, 46, 49, 51, 63, 64, 79, 171, 271 |
1042 | Standard of Care (SoC) | - | - | - | - | [1] 85 85 |
1043 | Standard of Care Chemotherapy | - | - | - | - | [1] 28 28 |
1044 | Standard of Care for Haemophilia A | - | - | - | - | [1] 288 288 |
1045 | Standard of Care FVIII Replacement therapy | - | - | - | - | [1] 288 288 |
1046 | Standard of care IV antibiotic(s) | - | - | - | - | [1] 299 299 |
1047 | Standard of Care Medications | - | - | - | - | [1] 171 171 |
1048 | Standard of care therapy | - | - | - | - | [1] 28 28 |
1049 | Standard of Care Treatment | - | - | - | - | [3] 53 53, 245, 246 |
1050 | Standard oxygen therapy/RA | [1] Oxygen Oxygen | [1] D00003
D00003
| - | - | [1] 299 299 |
1051 | Standard Plasma | - | - | - | - | [1] 64 64 |
1052 | Standard sinus rinse | - | - | - | - | [1] 299 299 |
1053 | Standard step-up care | - | - | - | - | [1] 96 96 |
1054 | Standard Steroid Treatment | - | - | - | - | [1] 85 85 |
1055 | Standard therapy | - | - | - | - | [2] 49 49, 97 |
1056 | Standard therapy (Excluding Immunosuppressants) | - | - | - | - | [1] 49 49 |
1057 | Standard therapy (Including Immunosuppressants) | - | - | - | - | [1] 49 49 |
1058 | Standard therapy (without eltrombopag): HD-DXM | [1] Eltrombopag Eltrombopag | - | - | - | [1] 63 63 |
1059 | Standard therapy of septic shock | - | - | - | - | [1] 60 60 |
1060 | Standard treatment with a conventional drug | - | - | - | - | [1] 13 13 |
1061 | Standard Vitamin D3 Supplementation | [1] Cholecalciferol Cholecalciferol | [1] D00188
D00188
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 60 60 |
1062 | Standard-dose vitamin D (400IU per day) | [1] Vitamin D Vitamin D | - | - | - | [1] 274 274 |
1063 | Standard-of-care treatment | - | - | - | - | [1] 49 49 |
1064 | Standardized anthocyanin-rich extract | - | - | - | - | [1] 97 97 |
1065 | Standardized cannabis extract | [1] Medical Cannabis Medical Cannabis | - | - | - | [1] 13 13 |
1066 | Standardized FMT | - | - | - | - | [1] 97 97 |
1067 | Standardized FODMAP | - | - | - | - | [1] 97 97 |
1068 | Standardized Ginkgo Biloba Extract (EGb 761 (r) | [1] Ginkgo biloba Ginkgo biloba | - | - | - | [1] 18 18 |
1069 | Standardized turmeric root extract | [1] Turmeric Turmeric | - | - | - | [1] 299 299 |
1070 | Standart of care | - | - | - | - | [1] 96 96 |
1071 | Standrd of Care treatment | - | - | - | - | [1] 64 64 |
1072 | Stanozolol | [1] Stanozolol Stanozolol | [1] D00444
D00444
| [1] AR AR 💬 | [4] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | [1] 60 60 |
1073 | STAPHYLOCOCCAL PROTEIN A | [1] Bevifimod Bevifimod | - | - | - | [1] 63 63 |
1074 | StarGen | - | - | - | - | [1] 301 301 |
1075 | Start adalimumab in monotherapy | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
1076 | Stasis | [1] Ferric sulfate Ferric sulfate | [1] D08922
D08922
| - | - | [2] 66 66, 97 |
1077 | Static, dynamic and functional balance exercises | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 6 6 |
1078 | Static, dynamic and functional balance exercises with dual task | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 6 6 |
1079 | Statin | - | - | - | - | [1] 13 13 |
1080 | Statins | - | - | - | - | [2] 46 46, 79 |
1081 | Status Post Lung Transplant | - | - | - | - | [1] 228 228 |
1082 | Stavudine | [1] Stavudine Stavudine | [1] D00445
D00445
| - | - | [1] 265 265 |
1083 | Stelara | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [6] 49 49, 56, 96, 97, 269, 271 |
1084 | Stelara (ustekinumab) | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 65 65 |
1085 | STELARA - 45 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 0.5 ML (90 MG/ML) 1 FLACONCINO | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1086 | STELARA - 90 MG - SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA(VETRO) 1 ML(90MG/ML) 1 SIRINGA PRERIEMPITA DA 1 ML | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1087 | STELARA - 90 MG SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) 1.0 ML (90 MG/ML) 1 FLACONCINO | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [2] 96 96, 97 |
1088 | STELARA 130 mg concentrate for solution for infusion | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1089 | Stelara 130mg / 26mL concentrate for solution for | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1090 | Stelara 130mg / 26mL concentrate for solution for infusion | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1091 | STELARA 90 mg solution for injection in pre-filled syringe | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1092 | Stelara 90mg/1ml solution for injecti | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1093 | Stelara 90mg/1ml solution for injection in pre-filled syringe (PFS) | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1094 | Stelara, Remicade, Entyvio, Humira, Remsima, Flixabi, Inflectra | [3] Infliximab Infliximab, Ustekinumab, Vedolizumab | [3] D02598
D02598
,
D08083
,
D09214
| [6] IL12A IL12A, IL12B, IL23A, ITGA4, ITGB7, TNF 💬 | [81] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
1095 | STELARA® | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [3] 49 49, 96, 97 |
1096 | STELARA¿ | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 96 96 |
1097 | Stem Cell | - | - | - | - | [2] 2 2, 113 |
1098 | Stem cell (HPC) implantation | - | - | - | - | [1] 2 2 |
1099 | Stem Cell Collection | - | - | - | - | [1] 28 28 |
1100 | Stem Cell Infusion | - | - | - | - | [5] 28 28, 60, 65, 284, 285 |
1101 | Stem Cell or Umbilical Cord Blood Transplantation | - | - | - | - | [1] 326 326 |
1102 | Stem cell therapy | - | - | - | - | [1] 5 5 |
1103 | Stem Cell Transplant | - | - | - | - | [6] 19 19, 20, 60, 65, 164, 284 |
1104 | Stem Cell Transplantation | - | - | - | - | [13] 13 13, 19, 20, 46, 51, 60, 62, 65, 90, 125, 164, 234, 326 |
1105 | Stem Cells | - | - | - | - | [4] 2 2, 4, 96, 113 |
1106 | Stem/progenitor cells transplantation | - | - | - | - | [2] 90 90, 301 |
1107 | Stempeucel(R) | - | - | - | - | [1] 47 47 |
1108 | Step-up | - | - | - | - | [1] 96 96 |
1109 | Stereotactic surgical device | - | - | - | - | [1] 2 2 |
1110 | Sterile Normal Saline (0.9% NaCl) | - | - | - | - | [3] 62 62, 234, 254 |
1111 | Sterile Normal Saline for Intravenous Use | - | - | - | - | [2] 85 85, 229 |
1112 | STERILE PYROGEN-FREE ISOTONIC NACL SOLUTE (0.9% W / V) | - | - | - | - | [1] 299 299 |
1113 | Sterile saline | - | - | - | - | [1] 227 227 |
1114 | Sterile saline for injection | - | - | - | - | [1] 97 97 |
1115 | Sterile saline solution | - | - | - | - | [1] 51 51 |
1116 | Sterile Water for Injection | [1] Water Water | [1] D00001
D00001
| - | - | [1] 78 78 |
1117 | Steroid | - | - | - | - | [1] 288 288 |
1118 | Steroid & Cyclosporin | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 222 222 |
1119 | Steroid and Proton Pump Inhibitor Therapy | - | - | - | - | [1] 98 98 |
1120 | Steroid Drug | - | - | - | - | [2] 46 46, 49 |
1121 | Steroid injections | - | - | - | - | [1] 70 70 |
1122 | Steroid pulse therapy group | - | - | - | - | [1] 85 85 |
1123 | Steroid Taper | - | - | - | - | [1] 49 49 |
1124 | Steroids | - | - | - | - | [7] 46 46, 50, 51, 63, 66, 96, 97 |
1125 | Steroids plus azathioprine | [1] Azathioprine Azathioprine | [2] D00238
D00238
,
D03033
| - | - | [1] 66 66 |
1126 | STG-001 | [1] STG-001 STG-001 | - | - | - | [1] 301 301 |
1127 | STI-6129 | - | - | - | - | [1] 28 28 |
1128 | STI571 | - | - | - | - | [2] 51 51, 86 |
1129 | Stilnoct | - | - | - | - | [1] 6 6 |
1130 | Stimulator OFF | - | - | - | - | [1] 6 6 |
1131 | Stimulator ON | - | - | - | - | [1] 6 6 |
1132 | Stiripentol | [1] Stiripentol Stiripentol | [1] D05928
D05928
| - | - | [1] 140 140 |
1133 | Stiripentolo | - | - | - | - | [1] 140 140 |
1134 | STK-001 | - | - | - | - | [1] 140 140 |
1135 | STK-001 - Multiple Ascending Doses | - | - | - | - | [1] 140 140 |
1136 | STK-001 - Single Ascending Doses | - | - | - | - | [1] 140 140 |
1137 | STNF-R1 | [1] Pegsunercept Pegsunercept | [1] D05393
D05393
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
1138 | STNM01 | - | - | - | - | [1] 97 97 |
1139 | STNM01 1.84 mg | - | - | - | - | [1] 97 97 |
1140 | Stool analysis | - | - | - | - | [1] 46 46 |
1141 | Stool samples | - | - | - | - | [1] 97 97 |
1142 | Stools | - | - | - | - | [1] 46 46 |
1143 | Strattera | - | - | - | - | [1] 6 6 |
1144 | Strensiq | [1] Asfotase alfa Asfotase alfa | [1] D10595
D10595
| [1] ALPL ALPL 💬 | [4] Biosynthesis of cofactors Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Thiamine metabolism 💬 | [1] 172 172 |
1145 | STRIMVELIS | - | - | - | - | [1] 65 65 |
1146 | Stromal Vascular fraction | - | - | - | - | [1] 51 51 |
1147 | Stromal vascular fraction (SVF) | - | - | - | - | [1] 96 96 |
1148 | Strontium ranelate | [1] Strontium ranelate Strontium ranelate | [1] D08468
D08468
| - | - | [1] 78 78 |
1149 | STS | - | - | - | - | [2] 50 50, 51 |
1150 | Study comparator ETI | - | - | - | - | [1] 166 166 |
1151 | Study Drug | - | - | - | - | [2] 6 6, 13 |
1152 | Study medication, azithromycin | [1] Azithromycin Azithromycin | [3] D02134
D02134
,
D06390
,
D07486
| - | - | [1] 299 299 |
1153 | Study of the gene expression profile | - | - | - | - | [1] 51 51 |
1154 | Study treatment PPI | - | - | - | - | [1] 166 166 |
1155 | STW5-II | - | - | - | - | [1] 97 97 |
1156 | STW5-II (Iberogast N, BAY98-7410) | - | - | - | - | [1] 97 97 |
1157 | STX107 | - | - | - | - | [1] 206 206 |
1158 | STX209 | - | - | - | - | [1] 206 206 |
1159 | Sub-Study: Nintedanib | [1] Nintedanib Nintedanib | [1] D10481
D10481
| [8] FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 | [34] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [1] 85 85 |
1160 | Sub-Study: Pirfenidone | [1] Pirfenidone Pirfenidone | [1] D01583
D01583
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 | [84] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 85 85 |
1161 | SUB0750MIG | - | - | - | - | [1] 13 13 |
1162 | SUB08293MIG | - | - | - | - | [1] 222 222 |
1163 | SUB09246MIG | - | - | - | - | [1] 18 18 |
1164 | SUB126308 | - | - | - | - | [1] 2 2 |
1165 | SUB16402MIG | - | - | - | - | [1] 227 227 |
1166 | SUB175614 | - | - | - | - | [1] 13 13 |
1167 | SUB180983 | - | - | - | - | [1] 107 107 |
1168 | SUB185183 | - | - | - | - | [1] 299 299 |
1169 | SUB195712 | - | - | - | - | [1] 19 19 |
1170 | SUB20016 | - | - | - | - | [1] 96 96 |
1171 | SUB21605 | - | - | - | - | [1] 225 225 |
1172 | SUB21634 | - | - | - | - | [1] 235 235 |
1173 | SUB22282 | - | - | - | - | [1] 13 13 |
1174 | Subcutaneous (SC) Abatacept | [1] Abatacept Abatacept | [1] D03203
D03203
| [2] CD80 CD80, CD86 💬 | [12] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | [1] 46 46 |
1175 | Subcutaneous Abatacept | [1] Abatacept Abatacept | [1] D03203
D03203
| [2] CD80 CD80, CD86 💬 | [12] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | [1] 46 46 |
1176 | Subcutaneous and intravenous prostacyclin | [1] Epoprostenol Epoprostenol | [2] D00106
D00106
,
D01337
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
1177 | Subcutaneous apomorphine | [1] Apomorphine Apomorphine | [2] D02004
D02004
,
D07460
| [2] DRD1 DRD1, DRD2 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1178 | Subcutaneous Beloranib in Suspension | [1] Beloranib Beloranib | - | - | - | [1] 193 193 |
1179 | Subcutaneous hydrocortisone | [1] Hydrocortisone Hydrocortisone | [1] D00088
D00088
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 |
1180 | Subcutaneous hydrocortisone 10mg | [1] Hydrocortisone Hydrocortisone | [1] D00088
D00088
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 6 6 |
1181 | Subcutaneous immunoglobulin | - | - | - | - | [1] 14 14 |
1182 | Subcutaneous immunoglobulin (SCIG) | - | - | - | - | [1] 11 11 |
1183 | Subcutaneous immunoglobulins | - | - | - | - | [1] 11 11 |
1184 | Subcutaneous tocilizumab | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 |
1185 | Subcutaneous tocilizumab 162mg/biweekly | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 |
1186 | Subcutaneous Treprostinil | [1] Treprostinil Treprostinil | [1] D06213
D06213
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
1187 | Subcutaneous Ustekinumab | [1] Ustekinumab Ustekinumab | [1] D09214
D09214
| [3] IL12A IL12A, IL12B, IL23A 💬 | [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 56 56 |
1188 | Subcutaneous(SC) Abatacept | [1] Abatacept Abatacept | [1] D03203
D03203
| [2] CD80 CD80, CD86 💬 | [12] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | [1] 46 46 |
1189 | Subcutanious administration | - | - | - | - | [1] 46 46 |
1190 | Subcuvia | - | - | - | - | [3] 14 14, 49, 65 |
1191 | Subgam | - | - | - | - | [1] 65 65 |
1192 | Subjects will undergo the 123-I IBVM imaging visit | - | - | - | - | [1] 6 6 |
1193 | Sublimated mare milk | - | - | - | - | [1] 93 93 |
1194 | Sublingual nitroglycerine | [1] Nitroglycerin Nitroglycerin | [1] D00515
D00515
| - | - | [1] 46 46 |
1195 | Sublingual tizanidine 12 mg | [1] Tizanidine Tizanidine | [2] D00776
D00776
,
D08611
| [3] ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 13 13 |
1196 | Sublingual videomicroscopy | - | - | - | - | [1] 288 288 |
1197 | Submucosal Bevacizumab | [1] Bevacizumab Bevacizumab | [1] D06409
D06409
| [1] VEGFA VEGFA 💬 | [24] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | [1] 227 227 |
1198 | Subretinal administration of rAAV2-VMD2-hMERTKRecombinant Adeno-Associated Virus | - | - | - | - | [1] 90 90 |
1199 | Subretinal injection of rAAV.hPDE6A | - | - | - | - | [1] 90 90 |
1200 | Subretinal injection of umbilical cord blood platelet-rich plasma (CB-PRP) | - | - | - | - | [1] 90 90 |
1201 | Sucralfate | [1] Sucralfate Sucralfate | [1] D00446
D00446
| - | - | [1] 98 98 |
1202 | Sucrose | [1] Sucrose Sucrose | [1] D00025
D00025
| - | - | [3] 62 62, 96, 97 |
1203 | Sucrosomial Iron | [1] Iron Iron | - | - | - | [1] 97 97 |
1204 | Sufentanil | [1] Sufentanil Sufentanil | [2] D00845
D00845
,
D05938
| [1] OPRM1 OPRM1 💬 | [3] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | [2] 70 70, 280 |
1205 | Sugar Extract | - | - | - | - | [2] 96 96, 97 |
1206 | Sugar pill | - | - | - | - | [8] 5 5, 6, 49, 67, 70, 86, 206, 210 |
1207 | Sulfadoxine | [1] Sulfadoxine Sulfadoxine | [1] D00580
D00580
| - | - | [1] 65 65 |
1208 | SULFAMETH | - | - | - | - | [1] 60 60 |
1209 | Sulfamethoxazole | [1] Sulfamethoxazole Sulfamethoxazole | [1] D00447
D00447
| - | - | [5] 44 44, 49, 61, 85, 299 |
1210 | SULFASALAZINE | [1] Sulfasalazine Sulfasalazine | [1] D00448
D00448
| - | - | [6] 46 46, 86, 94, 107, 270, 271 |
1211 | Sulfasalazine + Hydroxychloroquine | [2] Hydroxychloroquine Hydroxychloroquine, Sulfasalazine | [2] D00448
D00448
,
D08050
| - | - | [1] 46 46 |
1212 | Sulfasalazine, SSZ | [1] Sulfasalazine Sulfasalazine | [1] D00448
D00448
| - | - | [1] 271 271 |
1213 | Sulfate | [1] Sulfate ion Sulfate ion | - | - | - | [27] 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 218, 222, 226, 265, 296, 297, 299 |
1214 | Sulfate d'hydroxychloroquine | [2] Hydroxychloroquine Hydroxychloroquine, Sulfate ion | [1] D08050
D08050
| - | - | [1] 53 53 |
1215 | Sulfate, Magnesium | [2] Magnesium Magnesium, Sulfate ion | - | - | - | [1] 64 64 |
1216 | Sulfato de amikacina | [1] Amikacin Amikacin | [2] D00865
D00865
,
D02543
| - | - | [1] 299 299 |
1217 | Sulforaphane | [1] Sulforaphane Sulforaphane | - | - | - | [2] 6 6, 205 |
1218 | Sulfotanshinone Sodium Injection | - | - | - | - | [1] 224 224 |
1219 | Sulfur Colloid | [1] Gelatin Gelatin | [2] D00115
D00115
,
D06892
| - | - | [1] 299 299 |
1220 | SULFUR HEXAFLUORIDE | [1] Sulfur hexafluoride Sulfur hexafluoride | [1] D05962
D05962
| - | - | [2] 96 96, 215 |
1221 | Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON] | [1] Sulfur hexafluoride Sulfur hexafluoride | [1] D05962
D05962
| - | - | [1] 215 215 |
1222 | Sulindac | [1] Sulindac Sulindac | [1] D00120
D00120
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 206 206 |
1223 | Sulindac, dose strength 1 | [1] Sulindac Sulindac | [1] D00120
D00120
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 206 206 |
1224 | Sulindac, dose strength 2 | [1] Sulindac Sulindac | [1] D00120
D00120
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 206 206 |
1225 | Sulphamethoxazole | [1] Sulfamethoxazole Sulfamethoxazole | [1] D00447
D00447
| - | - | [1] 85 85 |
1226 | Sulphasalazine | - | - | - | - | [2] 46 46, 271 |
1227 | Sulphasalazine (SSZ) | - | - | - | - | [1] 271 271 |
1228 | Sulphasalazine + Hydroxychloroquine OR Prednisolone | [2] Hydroxychloroquine Hydroxychloroquine, Prednisolone | [9] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
,
D08050
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
1229 | Sulphasalazine 500 mg En-Tabs | - | - | - | - | [1] 271 271 |
1230 | Sulphsalazine, Pentasa, Asacol, Colazide, Depentum | - | - | - | - | [1] 97 97 |
1231 | Sulphur hexafluoride | [1] Sulfur hexafluoride Sulfur hexafluoride | [1] D05962
D05962
| - | - | [1] 96 96 |
1232 | Sumanirole | [1] Sumanirole Sumanirole | - | - | - | [1] 6 6 |
1233 | Sunflower oil | [1] Sunflower oil Sunflower oil | [1] D09006
D09006
| - | - | [3] 46 46, 240, 299 |
1234 | Sunitinib | [1] Sunitinib Sunitinib | [2] D06402
D06402
,
D08552
| [9] CSF1 CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬 | [39] Acute myeloid leukemia Acute myeloid leukemia, Alzheimer disease, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, TNF signaling pathway, Thyroid cancer, Transcriptional misregulation in cancer, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 28 28, 34 |
1235 | Sunitinib malate | [1] Sunitinib Sunitinib | [2] D06402
D06402
,
D08552
| [9] CSF1 CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬 | [39] Acute myeloid leukemia Acute myeloid leukemia, Alzheimer disease, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, TNF signaling pathway, Thyroid cancer, Transcriptional misregulation in cancer, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 28 28 |
1236 | SUNPG1622 I dose | - | - | - | - | [1] 271 271 |
1237 | Sunphenon | - | - | - | - | [2] 13 13, 113 |
1238 | Sunphenon EGCG | [1] Epigallocatechin gallate Epigallocatechin gallate | - | - | - | [3] 13 13, 17, 113 |
1239 | Sunphenon EGCg TM | - | - | - | - | [1] 13 13 |
1240 | Suplatast tosilate | - | - | - | - | [1] 226 226 |
1241 | Supplement nutritional supporting | - | - | - | - | [1] 291 291 |
1242 | Supplemental oxygen via a mask | [1] Oxygen Oxygen | [1] D00003
D00003
| - | - | [1] 88 88 |
1243 | Supplementation | - | - | - | - | [1] 6 6 |
1244 | Supplementation with vitamin D2/D3 | [1] Ergocalciferol Ergocalciferol | [1] D00187
D00187
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 299 299 |
1245 | Supportive and immunosuppressive therapy | - | - | - | - | [1] 66 66 |
1246 | Supportive therapy | - | - | - | - | [1] 66 66 |
1247 | Supportive therapy with: ACE-inhibitor / ARB / Statin | - | - | - | - | [1] 66 66 |
1248 | Supressi. T-Diet plus Range | - | - | - | - | [1] 6 6 |
1249 | Suramin | [1] Suramin Suramin | - | - | - | [1] 331 331 |
1250 | Surgery to implant human CNS stem cells (HuCNS-SC) | - | - | - | - | [1] 19 19 |
1251 | Surgery treatment | - | - | - | - | [1] 291 291 |
1252 | Surgical Septal Myectomy | - | - | - | - | [1] 58 58 |
1253 | Survival of Motor Neuron 2 (SMN2) Splicing Modulator Antisense Oligonucleotide | - | - | - | - | [1] 3 3 |
1254 | Suspension containing 250 embryonated, viable Trichuris suis ova (TSO)/15ml | - | - | - | - | [1] 96 96 |
1255 | Suspension containing 250 embryonated, viable TSO/15ml | - | - | - | - | [1] 96 96 |
1256 | Suspension containing 2500 embryonated, viable Trichuris suis ova (TSO)/15ml | - | - | - | - | [1] 96 96 |
1257 | Suspension containing 2500 embryonated, viable TSO/15ml | - | - | - | - | [1] 96 96 |
1258 | SUSPENSION CONTAINING 7500 EMBRYONATED VIABLE TRICHURIS SUIS OVA/15ML | - | - | - | - | [1] 97 97 |
1259 | Suspension containing 7500 embryonated, viable Trichuris suis ova (TSO)/15ml | - | - | - | - | [1] 96 96 |
1260 | Suspension de microbiote fécal | - | - | - | - | [1] 97 97 |
1261 | Suspension IR | - | - | - | - | [1] 46 46 |
1262 | Suspension media | - | - | - | - | [1] 13 13 |
1263 | Suspension of 7500 embryonated, viable TSO/15ml | - | - | - | - | [1] 96 96 |
1264 | Suspension of adipose derived autologous adult stem cells | - | - | - | - | [1] 96 96 |
1265 | Suspension of autologous CD34+cells transduced with the G1XCGD viral vector | - | - | - | - | [1] 65 65 |
1266 | Suspension of human autologous MSC 3P in 1,5 ml | - | - | - | - | [1] 2 2 |
1267 | Suspension of human autologous MSC 3P in 1.5 ml | - | - | - | - | [1] 2 2 |
1268 | Sustained release growth hormone | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
1269 | Sustained-release oral dalfampridine | [1] Dalfampridine Dalfampridine | [1] D04127
D04127
| [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 |
1270 | Sustained-release recombinant human GH (SR-rhGH) | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
1271 | Sustanon | - | - | - | - | [1] 113 113 |
1272 | Sustanon (testosterone) | [1] Testosterone Testosterone | [6] D00075
D00075
,
D00957
,
D00958
,
D00959
,
D06085
,
D06087
| [1] AR AR 💬 | [4] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | [1] 113 113 |
1273 | Sustanon 250 | - | - | - | - | [1] 113 113 |
1274 | SUSTIVA | [1] Efavirenz Efavirenz | [1] D00896
D00896
| - | - | [1] 265 265 |
1275 | Sutent®/Sunitinib | [1] Sunitinib Sunitinib | [2] D06402
D06402
,
D08552
| [9] CSF1 CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬 | [39] Acute myeloid leukemia Acute myeloid leukemia, Alzheimer disease, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, TNF signaling pathway, Thyroid cancer, Transcriptional misregulation in cancer, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 34 34 |
1276 | Sutimlimab | [1] Sutimlimab Sutimlimab | [1] D11530
D11530
| [1] C1S C1S 💬 | [5] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 61 61 |
1277 | Sutimlimab (BIVV009) | [1] Sutimlimab Sutimlimab | [1] D11530
D11530
| [1] C1S C1S 💬 | [5] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 61 61 |
1278 | Suvodirsen | - | - | - | - | [1] 113 113 |
1279 | Suvorexant | [1] Suvorexant Suvorexant | [1] D10082
D10082
| [2] HCRTR1 HCRTR1, HCRTR2 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 5 5, 6, 13 |
1280 | SVS20 | - | - | - | - | [1] 53 53 |
1281 | Swallowed fluticasone | [1] Fluticasone Fluticasone | [1] D07981
D07981
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
1282 | Sweet polvilho | - | - | - | - | [1] 257 257 |
1283 | Switch to Myfortic | [1] Mycophenolic acid Mycophenolic acid | [1] D05096
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [1] 49 49 |
1284 | SXR1096 | - | - | - | - | [1] 160 160 |
1285 | Symbicort | - | - | - | - | [2] 85 85, 228 |
1286 | Symbiotic Formula with DHA and antioxidants | - | - | - | - | [1] 299 299 |
1287 | Symdeko | [1] Ivacaftor Ivacaftor | [1] D09916
D09916
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
1288 | Symdeko/Trikafta | [2] Ivacaftor Ivacaftor, Tezacaftor | [2] D09916
D09916
,
D11041
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
1289 | Symkevi | [1] Ivacaftor Ivacaftor | [1] D09916
D09916
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
1290 | Symkevi 100mg/150mg Film-coated tablets | [1] Ivacaftor Ivacaftor | [1] D09916
D09916
| [1] CFTR CFTR 💬 | [8] ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | [1] 299 299 |
1291 | Symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin) | [3] Aldosterone Aldosterone, Angiotensin II, Calcium | [3] D00150
D00150
,
D02014
,
D10528
| [3] AGTR1 AGTR1, AGTR2, NR3C2 💬 | [17] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 222 222 |
1292 | Symptomatic Treatment, Steroids, Immunosuppressive Agents( azathioprine, tacrolimus, Mycophenolate Mofetil) | [4] Azathioprine Azathioprine, Mycophenolate mofetil, Mycophenolic acid, Tacrolimus | [8] D00107
D00107
,
D00238
,
D00752
,
D03033
,
D05094
,
D05095
,
D05096
,
D08556
| [7] IMPDH1 IMPDH1, IMPDH2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [36] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 11 11 |
1293 | Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg) | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 11 11 |
1294 | SYN115 | - | - | - | - | [1] 6 6 |
1295 | SYN115 Tablets, 60 mg | - | - | - | - | [1] 6 6 |
1296 | SYN120 | - | - | - | - | [1] 6 6 |
1297 | Synacthen | - | - | - | - | [1] 78 78 |
1298 | Synacthen (Tetracosactrin) | [1] Tetracosactide Tetracosactide | [1] D00284
D00284
| [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 78 78 |
1299 | Synacthen Ampoules 250 mcg | - | - | - | - | [1] 113 113 |
1300 | Synacthen Ampoules 250 microgrammi | - | - | - | - | [1] 113 113 |
1301 | Synacthen Depot | [1] Tetracosactide Tetracosactide | [1] D00284
D00284
| [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [3] 83 83, 145, 222 |
1302 | Synacthen Depot 1mg | [1] Tetracosactide Tetracosactide | [1] D00284
D00284
| [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 222 222 |
1303 | SYNB1020 | - | - | - | - | [1] 251 251 |
1304 | SYNB1618 | - | - | - | - | [1] 240 240 |
1305 | SYNB1934 | - | - | - | - | [1] 240 240 |
1306 | Synbiotic | - | - | - | - | [1] 96 96 |
1307 | Synbiotic (Synergy I / B.longum) | - | - | - | - | [1] 96 96 |
1308 | Synergy | - | - | - | - | [1] 240 240 |
1309 | Synergy-1 | - | - | - | - | [1] 97 97 |
1310 | Synergy1 | - | - | - | - | [1] 97 97 |
1311 | Syngeneic Bone Marrow Transplantation | - | - | - | - | [3] 11 11, 13, 14 |
1312 | Synovial biopsy | - | - | - | - | [1] 46 46 |
1313 | Synrinse | - | - | - | - | [1] 299 299 |
1314 | SYNT001 | - | - | - | - | [1] 61 61 |
1315 | Synthetic 15-amino-acid macrocyclic peptide | - | - | - | - | [1] 62 62 |
1316 | Synthetic 15-amino-acid macrocyclic peptide acylated with a ethyleneglycol24 | - | - | - | - | [1] 62 62 |
1317 | Synthetic 15-amino-acid macrocyclic peptide acylated with a ethyleneglycol24 palmitoylated linker | - | - | - | - | [1] 62 62 |
1318 | Synthetic 15-amino-acid macrocyclic peptide acylated with a polyethyleneglycol palmitoylated linker | - | - | - | - | [1] 62 62 |
1319 | Synthetic DMARD(s) | - | - | - | - | [1] 46 46 |
1320 | Synthetic Human Parathyroid Hormone 1-34 | [1] Parathyroid hormone Parathyroid hormone | [1] D05364
D05364
| [2] PTH1R PTH1R, PTH2R 💬 | [3] Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | [1] 235 235 |
1321 | Synthetic human secretin | [1] Secretin human Secretin human | - | - | - | [1] 298 298 |
1322 | Synthetic Oxytocin | [1] Oxytocin Oxytocin | [1] D00089
D00089
| [1] OXTR OXTR 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1323 | Synthetic PreImplantation Factor | [1] Preimplantation factor Preimplantation factor | - | - | - | [1] 95 95 |
1324 | Synthetic stereopure antisense oligonucleotide targeting human C9orf72 hexanucleotide repeat-containing mRNA transcripts | - | - | - | - | [2] 2 2, 127 |
1325 | Syntocinon | [1] Oxytocin Oxytocin | [1] D00089
D00089
| [1] OXTR OXTR 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [3] 6 6, 127, 193 |
1326 | Syntocinon 40 IU/ml nasal spray | [1] Oxytocin Oxytocin | [1] D00089
D00089
| [1] OXTR OXTR 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
1327 | Syntocinon nasal spray | [1] Oxytocin Oxytocin | [1] D00089
D00089
| [1] OXTR OXTR 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [1] 193 193 |
1328 | Syntocinon®/- Spray | [1] Oxytocin Oxytocin | [1] D00089
D00089
| [1] OXTR OXTR 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | [1] 193 193 |
1329 | Syntropin | - | - | - | - | [1] 78 78 |
1330 | Systane Ultra UD | - | - | - | - | [1] 53 53 |
1331 | Systematic chemotherapy and antibodies | - | - | - | - | [1] 62 62 |
1332 | Systemic anticoagulation | - | - | - | - | [1] 88 88 |
1333 | Systemic chemotherapy and antibodies | - | - | - | - | [2] 62 62, 326 |
1334 | Systemic non-biological treatments | - | - | - | - | [2] 46 46, 271 |
1335 | Sübetaholzwurzel 1ml/10ml | - | - | - | - | [1] 97 97 |
1336 | Süßholzwurzel 1ml/10ml | - | - | - | - | [1] 97 97 |